Ralf Gold - Publications

Affiliations: 
St. Josefs Hopital, Denver, CO, United States 

500 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2022 Ringelstein M, Ayzenberg I, Lindenblatt G, Fischer K, Gahlen A, Novi G, Hayward-Könnecke H, Schippling S, Rommer PS, Kornek B, Zrzavy T, Biotti D, Ciron J, Audoin B, Berthele A, ... ... Gold R, et al. Interleukin-6 Receptor Blockade in Treatment-Refractory MOG-IgG-Associated Disease and Neuromyelitis Optica Spectrum Disorders. Neurology(R) Neuroimmunology & Neuroinflammation. 9. PMID 34785575 DOI: 10.1212/NXI.0000000000001100  1
2021 Fleischer V, Ciolac D, Gonzalez-Escamilla G, Grothe M, Strauss S, Molina Galindo LS, Radetz A, Salmen A, Lukas C, Klotz L, Meuth SG, Bayas A, Paul F, Hartung HP, Heesen C, ... ... Gold R, et al. Subcortical volumes as early predictors of fatigue in multiple sclerosis. Annals of Neurology. PMID 34967456 DOI: 10.1002/ana.26290  1
2021 Richter D, Charles James J, Ebert A, Katsanos AH, Mazul-Wach L, Ruland Q, Gold R, Juckel G, Krogias C. Selective Serotonin Reuptake Inhibitors for the Prevention of Post-Stroke Depression: A Systematic Review and Meta-Analysis. Journal of Clinical Medicine. 10. PMID 34945207 DOI: 10.3390/jcm10245912  1
2021 Thiel S, Ciplea AI, Gold R, Hellwig K. The German Multiple Sclerosis and Pregnancy Registry: rationale, objective, design, and first results. Therapeutic Advances in Neurological Disorders. 14: 17562864211054956. PMID 34840606 DOI: 10.1177/17562864211054956  1
2021 Klimas R, Sgodzai M, Motte J, Mohamad N, Renk P, Blusch A, Grüter T, Pedreiturria X, Gobrecht P, Fischer D, Schneider-Gold C, Reinacher-Schick A, Tannapfel A, Yoon MS, Gold R, et al. Dose-dependent immunomodulatory effects of bortezomib in experimental autoimmune neuritis. Brain Communications. 3: fcab238. PMID 34708206 DOI: 10.1093/braincomms/fcab238  1
2021 Fisse AL, Pitarokoili K, Gold R. Nerve Ultrasound Protocol to Detect Dysimmune Neuropathies. Journal of Visualized Experiments : Jove. PMID 34694291 DOI: 10.3791/62900  1
2021 Grüter T, Motte J, Bulut Y, Kordes A, Athanasopoulos D, Fels M, Schneider-Gold C, Gold R, Fisse AL, Pitarokoili K. Axonal damage determines clinical disability in chronic inflammatory demyelinating polyradiculoneuropathy: a prospective cohort study in different CIDP subtypes and disease stages. European Journal of Neurology. PMID 34687104 DOI: 10.1111/ene.15156  1
2021 Gold R, Fätkenheuer G, Hartung HP, Kleinschnitz C, Marks R, Maschke M, Bayas A, Löbermann M, Zettl UK, Wiendl H. Vaccination in multiple sclerosis patients treated with highly effective disease-modifying drugs: an overview with consideration of cladribine tablets. Therapeutic Advances in Neurological Disorders. 14: 17562864211019598. PMID 34671422 DOI: 10.1177/17562864211019598  1
2021 Biesalski AS, Hoffjan S, Schneider R, Nguyen HP, Dekomien G, Lücke T, Schneider-Gold C, Matusche B, Gold R, Ayzenberg I. Phoenix from the ashes: dramatic improvement in severe late-onset methylenetetrahydrofolate reductase (MTHFR) deficiency with a complete loss of vision. Journal of Neurology. PMID 34657180 DOI: 10.1007/s00415-021-10841-x  1
2021 Filippi M, Danesi R, Derfuss T, Duddy M, Gallo P, Gold R, Havrdová EK, Kornek B, Saccà F, Tintoré M, Weber J, Trojano M. Early and unrestricted access to high-efficacy disease-modifying therapies: a consensus to optimize benefits for people living with multiple sclerosis. Journal of Neurology. PMID 34626224 DOI: 10.1007/s00415-021-10836-8  1
2021 Haghikia A, Zimmermann F, Schumann P, Jasina A, Roessler J, Schmidt D, Heinze P, Kaisler J, Nageswaran V, Aigner A, Ceglarek U, Cineus R, Hegazy AN, van der Vorst EPC, Döring Y, ... ... Gold R, et al. Propionate attenuates atherosclerosis by immune-dependent regulation of intestinal cholesterol metabolism. European Heart Journal. PMID 34597388 DOI: 10.1093/eurheartj/ehab644  1
2021 Scherbaum R, Kwon EH, Richter D, Bartig D, Gold R, Krogias C, Tönges L. Hospital Admissions for Neurodegenerative Diseases during the First Wave of the COVID-19 Pandemic: A Nationwide Cross-Sectional Study from Germany. Brain Sciences. 11. PMID 34573238 DOI: 10.3390/brainsci11091219  1
2021 Fels M, Fisse AL, Schwake C, Motte J, Athanasopoulos D, Grüter T, Spenner M, Breuer T, Starz K, Heinrich D, Grond M, Keyvani K, Appeltshauser L, Doppler K, Sommer C, ... ... Gold R, et al. Report of a fulminant anti-pan-neurofascin-associated neuropathy responsive to rituximab and bortezomib. Journal of the Peripheral Nervous System : Jpns. PMID 34486194 DOI: 10.1111/jns.12465  1
2021 Pitarokoili K, Maier A, de Moya Rubio EC, Hahn K, Wallukat G, Athanasopoulos D, Grüter T, Motte J, Fisse AL, Gold R. Maintenance therapy with subcutaneous immunoglobulin in a patient with immune-mediated neuropathic postural tachycardia syndrome. Journal of Translational Autoimmunity. 4: 100112. PMID 34471867 DOI: 10.1016/j.jtauto.2021.100112  1
2021 Gold R, Arnold DL, Bar-Or A, Fox RJ, Kappos L, Mokliatchouk O, Jiang X, Lyons J, Kapadia S, Miller C. Long-term safety and efficacy of dimethyl fumarate for up to 13 years in patients with relapsing-remitting multiple sclerosis: Final ENDORSE study results. Multiple Sclerosis (Houndmills, Basingstoke, England). 13524585211037909. PMID 34465252 DOI: 10.1177/13524585211037909  1
2021 Backhaus JF, Pflaumbaum A, Krogias C, Kreimer F, Mügge A, Gold R, Gotzmann M. Short- and long-term outcome of patients with spontaneous echo contrast or thrombus in the left atrial appendage in the era of the direct acting anticoagulants. Clinical Research in Cardiology : Official Journal of the German Cardiac Society. PMID 34436659 DOI: 10.1007/s00392-021-01926-8  1
2021 Faissner S, Richter D, Ceylan U, Schneider-Gold C, Gold R. COVID-19 mRNA vaccine induced rhabdomyolysis and fasciitis. Journal of Neurology. PMID 34435250 DOI: 10.1007/s00415-021-10768-3  1
2021 Linker RA, Gold R. [Immunotherapy and personalized treatment of multiple sclerosis]. Der Nervenarzt. PMID 34427718 DOI: 10.1007/s00115-021-01176-z  1
2021 Wiendl H, Gold R, Berger T, Derfuss T, Linker R, Mäurer M, Aktas O, Baum K, Berghoff M, Bittner S, Chan A, Czaplinski A, Deisenhammer F, Di Pauli F, Du Pasquier R, et al. Multiple Sclerosis Therapy Consensus Group (MSTCG): position statement on disease-modifying therapies for multiple sclerosis (white paper). Therapeutic Advances in Neurological Disorders. 14: 17562864211039648. PMID 34422112 DOI: 10.1177/17562864211039648  1
2021 Richter D, Faissner S, Bartig D, Tönges L, Hellwig K, Ayzenberg I, Krogias C, Gold R. Multiple sclerosis is not associated with an increased risk for severe COVID-19: a nationwide retrospective cross-sectional study from Germany. Neurological Research and Practice. 3: 42. PMID 34399858 DOI: 10.1186/s42466-021-00143-y  1
2021 Dohrn MF, Ellrichmann G, Pjontek R, Lukas C, Panse J, Gold R, Schulz JB, Gess B, Tauber SC. Progressive multifocal leukoencephalopathy and immune reconstitution inflammatory syndrome in seven patients with sarcoidosis: a critical discussion of treatment and prognosis. Therapeutic Advances in Neurological Disorders. 14: 17562864211035543. PMID 34377151 DOI: 10.1177/17562864211035543  1
2021 Wiendl H, Gold R, Zipp F. Multiple sclerosis therapy consensus group (MSTCG): answers to the discussion questions. Neurological Research and Practice. 3: 44. PMID 34362473 DOI: 10.1186/s42466-021-00140-1  1
2021 Motte J, Grüter T, Fisse AL, Bulut Y, Stykova Z, Greiner T, Enax-Krumova E, Yoon MS, Gold R, Tegenthoff M, Sturm D, Pitarokoili K. Corneal inflammatory cell infiltration predicts disease activity in chronic inflammatory demyelinating polyneuropathy. Scientific Reports. 11: 15150. PMID 34312451 DOI: 10.1038/s41598-021-94605-7  1
2021 Wiendl H, Gold R, Berger T, Derfuss T, Linker R, Mäurer M, Stangel M, Aktas O, Baum K, Berghoff M, Bittner S, Chan A, Czaplinski A, Deisenhammer F, Di Pauli F, et al. [Multiple sclerosis treatment consensus group (MSTCG): position paper on disease-modifying treatment of multiple sclerosis 2021 (white paper)]. Der Nervenarzt. PMID 34297142 DOI: 10.1007/s00115-021-01157-2  1
2021 Richter D, Faissner S, Bartig D, Tönges L, Hellwig K, Ayzenberg I, Krogias C, Gold R. The impact of the COVID-19 pandemic on hospitalizations and plasmapheresis therapy in multiple sclerosis and neuromyelitis optica spectrum disorder: a nationwide analysis from Germany. Therapeutic Advances in Neurological Disorders. 14: 17562864211030656. PMID 34285719 DOI: 10.1177/17562864211030656  1
2021 Gili-Kovács J, Hoepner R, Salmen A, Bagnoud M, Gold R, Chan A, Briner M. An algorithm using clinical data to predict the optimal individual glucocorticoid dosage to treat multiple sclerosis relapses. Therapeutic Advances in Neurological Disorders. 14: 17562864211020074. PMID 34211583 DOI: 10.1177/17562864211020074  1
2021 Rohmann R, Kühn E, Scherbaum R, Hilker L, Kools S, Scholz L, Müller K, Huckemann S, Schneider-Gold C, Gold R, Pitarokoili K, Tönges L, Kwon EH. Prevalence and Characteristics of Polyneuropathy in Atypical Parkinsonian Syndromes: An Explorative Study. Brain Sciences. 11. PMID 34209067 DOI: 10.3390/brainsci11070879  1
2021 Kogel AK, Gold R, Schneider R. CMV meningitis associated with dimethyl fumarate therapy-induced lymphopenia in a multiple sclerosis patient. Journal of Neurology. PMID 34175973 DOI: 10.1007/s00415-021-10661-z  1
2021 Haase S, Mäurer J, Duscha A, Lee DH, Balogh A, Gold R, Müller DN, Haghikia A, Linker RA. Propionic Acid Rescues High-Fat Diet Enhanced Immunopathology in Autoimmunity Effects on Th17 Responses. Frontiers in Immunology. 12: 701626. PMID 34140958 DOI: 10.3389/fimmu.2021.701626  1
2021 James JC, Richter D, Tomaske L, Schneider R, Lukas C, Kaemmerer F, Gold R, Krogias C. Usefulness of Computed Tomographic Perfusion Imaging for Appropriate Diagnosis of Acute Cerebral Vessel Occlusion in Case of Anatomic Variations of the Circle of Willis. Neurointervention. PMID 34134184 DOI: 10.5469/neuroint.2021.00136  1
2021 Ayzenberg I, Richter D, Henke E, Asseyer S, Paul F, Trebst C, Hümmert MW, Havla J, Kümpfel T, Ringelstein M, Aktas O, Wildemann B, Jarius S, Häußler V, Stellmann JP, ... ... Gold R, et al. Pain, Depression, and Quality of Life in Neuromyelitis Optica Spectrum Disorder: A Cross-Sectional Study of 166 AQP4 Antibody-Seropositive Patients. Neurology(R) Neuroimmunology & Neuroinflammation. 8. PMID 34108267 DOI: 10.1212/NXI.0000000000000985  1
2021 Havla J, Pakeerathan T, Schwake C, Bennett JL, Kleiter I, Felipe-Rucián A, Joachim SC, Lotz-Havla AS, Kümpfel T, Krumbholz M, Wendel EM, Reindl M, Thiels C, Lücke T, Hellwig K, ... Gold R, et al. Age-dependent favorable visual recovery despite significant retinal atrophy in pediatric MOGAD: how much retina do you really need to see well? Journal of Neuroinflammation. 18: 121. PMID 34051804 DOI: 10.1186/s12974-021-02160-9  1
2021 Scherbaum R, Kwon EH, Richter D, Bartig D, Gold R, Krogias C, Tönges L. Clinical Profiles and Mortality of COVID-19 Inpatients with Parkinson's Disease in Germany. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 33942924 DOI: 10.1002/mds.28586  1
2021 Richter D, Scherbaum R, Bartig D, Gold R, Krogias C, Tönges L. Analysis of nationwide multimodal complex treatment and drug pump therapy in Parkinson's disease in times of COVID-19 pandemic in Germany. Parkinsonism & Related Disorders. 85: 109-113. PMID 33845342 DOI: 10.1016/j.parkreldis.2021.03.006  1
2021 Fisse AL, Katsanos AH, Gold R, Pitarokoili K, Krogias C. Cross-sectional area reference values for peripheral nerve ultrasound in adults: a systematic review and meta-analysis - part III: Cervical nerve roots and vagal nerve. European Journal of Neurology. PMID 33838065 DOI: 10.1111/ene.14862  1
2021 Athanasopoulos D, Motte J, Grüter T, Köse N, Yoon MS, Otto S, Schneider-Gold C, Gold R, Fisse AL, Pitarokoili K. Evaluation of the EFNS/PNS diagnostic criteria in a cohort of CIDP patients. Annals of Clinical and Translational Neurology. PMID 33826247 DOI: 10.1002/acn3.51357  1
2021 Wundes A, Wray S, Gold R, Singer BA, Jasinska E, Ziemssen T, de Seze J, Repovic P, Chen H, Hanna J, Messer J, Miller C, Naismith RT. Improved gastrointestinal profile with diroximel fumarate is associated with a positive impact on quality of life compared with dimethyl fumarate: results from the randomized, double-blind, phase III EVOLVE-MS-2 study. Therapeutic Advances in Neurological Disorders. 14: 1756286421993999. PMID 33796143 DOI: 10.1177/1756286421993999  1
2021 Fisse AL, Katsanos AH, Gold R, Krogias C, Pitarokoili K. Cross-sectional area reference values for peripheral nerve ultrasound in adults: a systematic review and meta-analysis - part II: Lower extremity nerves. European Journal of Neurology. PMID 33794049 DOI: 10.1111/ene.14850  1
2021 Schneider R, Matusche B, Genç E, Gold R, Bellenberg B, Lukas C. Microstructural White Matter Alterations in Cognitively Impaired Patients at Early Stages of Multiple Sclerosis. Clinical Neuroradiology. PMID 33787958 DOI: 10.1007/s00062-021-01010-8  1
2021 Motte J, Fisse AL, Köse N, Grüter T, Mork H, Athanasopoulos D, Fels M, Otto S, Siglienti I, Schneider-Gold C, Hellwig K, Yoon MS, Gold R, Pitarokoili K. Treatment response to cyclophosphamide, rituximab, and bortezomib in chronic immune-mediated sensorimotor neuropathies: a retrospective cohort study. Therapeutic Advances in Neurological Disorders. 14: 1756286421999631. PMID 33747132 DOI: 10.1177/1756286421999631  1
2021 Hoffmann O, Gold R. [Disease-modifying treatment of secondary progressive multiple sclerosis]. Der Nervenarzt. PMID 33656569 DOI: 10.1007/s00115-021-01080-6  0.01
2021 Fisse AL, Katsanos AH, Gold R, Pitarokoili K, Krogias C. Cross-sectional area reference values for peripheral nerve ultrasound in adults: a systematic review and meta-analysis - part I: Upper extremity nerves. European Journal of Neurology. PMID 33527596 DOI: 10.1111/ene.14759  1
2021 Wipke BT, Hoepner R, Strassburger-Krogias K, Thomas AM, Gianni D, Szak S, Brennan MS, Pistor M, Gold R, Chan A, Scannevin RH. Different Fumaric Acid Esters Elicit Distinct Pharmacologic Responses. Neurology(R) Neuroimmunology & Neuroinflammation. 8. PMID 33468560 DOI: 10.1212/NXI.0000000000000950  1
2021 Asseyer S, Henke E, Trebst C, Hümmert MW, Wildemann B, Jarius S, Ringelstein M, Aktas O, Pawlitzki M, Korsen M, Klotz L, Siebert N, Ruprecht K, Bellmann-Strobl J, Wernecke KD, ... ... Gold R, et al. Pain, depression and quality of life in adults with MOG-antibody associated disease. European Journal of Neurology. PMID 33423336 DOI: 10.1111/ene.14729  1
2021 Fisse AL, Fiegert S, Stoykova Z, Brünger J, Athanasopoulos D, Grüter T, Motte J, Gold R, Pitarokoili K. Increased muscle echointensity correlates with clinical disability and muscle strength in chronic inflammatory demyelinating polyneuropathy. European Journal of Neurology. PMID 33404183 DOI: 10.1111/ene.14716  1
2021 Ostkamp P, Salmen A, Pignolet B, Görlich D, Andlauer TFM, Schulte-Mecklenbeck A, Gonzalez-Escamilla G, Bucciarelli F, Gennero I, Breuer J, Antony G, Schneider-Hohendorf T, Mykicki N, Bayas A, Then Bergh F, ... ... Gold R, et al. Sunlight exposure exerts immunomodulatory effects to reduce multiple sclerosis severity. Proceedings of the National Academy of Sciences of the United States of America. 118. PMID 33376202 DOI: 10.1073/pnas.2018457118  1
2021 Schneider R, Bellenberg B, Gisevius B, Hirschberg S, Sankowski R, Prinz M, Gold R, Lukas C, Haghikia A. Chitinase 3-like 1 and neurofilament light chain in CSF and CNS atrophy in MS. Neurology(R) Neuroimmunology & Neuroinflammation. 8. PMID 33172960 DOI: 10.1212/NXI.0000000000000906  1
2020 Chan A, Rose J, Alvarez E, Bar-Or A, Butzkueven H, Fox RJ, Gold R, Gudesblatt M, Haartsen J, Spelman T, Wright K, Ferraro D, Sola P, Hodgkinson S, Kalincik T, et al. Lymphocyte reconstitution after DMF discontinuation in clinical trial and real-world patients with MS. Neurology. Clinical Practice. 10: 510-519. PMID 33510947 DOI: 10.1212/CPJ.0000000000000800  1
2020 Benedict RHB, Tomic D, Cree BA, Fox R, Giovannoni G, Bar-Or A, Gold R, Vermersch P, Pohlmann H, Wright I, Karlsson G, Dahlke F, Wolf C, Kappos L. Siponimod and cognition in secondary progressive multiple sclerosis: EXPAND secondary analyses. Neurology. PMID 33328324 DOI: 10.1212/WNL.0000000000011275  1
2020 Fisse AL, Motte J, Grüter T, Sgodzai M, Pitarokoili K, Gold R. Comprehensive approaches for diagnosis, monitoring and treatment of chronic inflammatory demyelinating polyneuropathy. Neurological Research and Practice. 2: 42. PMID 33324942 DOI: 10.1186/s42466-020-00088-8  1
2020 Schwake C, Gold R. Severe pneumonia with formation of a pulmonary cavity associated with long-term rituximab therapy in multiple sclerosis. Neurological Research and Practice. 2: 30. PMID 33324932 DOI: 10.1186/s42466-020-00074-0  1
2020 Beyer L, Günther R, Koch JC, Klebe S, Hagenacker T, Lingor P, Biesalski AS, Hermann A, Nabers A, Gold R, Tönges L, Gerwert K. TDP-43 as structure-based biomarker in amyotrophic lateral sclerosis. Annals of Clinical and Translational Neurology. PMID 33263951 DOI: 10.1002/acn3.51256  1
2020 Fisse AL, May C, Motte J, Pedreiturria X, Breuer TGK, Schneider-Gold C, Marcus K, Gold R, Yoon MS, Pitarokoili K. New Approaches to Critical Illness Polyneuromyopathy: High-Resolution Neuromuscular Ultrasound Characteristics and Cytokine Profiling. Neurocritical Care. PMID 33236290 DOI: 10.1007/s12028-020-01148-2  1
2020 Motte J, Gold R. High-dose biotin in multiple sclerosis: the end of the road. The Lancet. Neurology. 19: 965-966. PMID 33222766 DOI: 10.1016/S1474-4422(20)30353-7  1
2020 Cree BA, Magnusson B, Rouyrre N, Fox RJ, Giovannoni G, Vermersch P, Bar-Or A, Gold R, Piani Meier D, Karlsson G, Tomic D, Wolf C, Dahlke F, Kappos L. Siponimod: Disentangling disability and relapses in secondary progressive multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). 1352458520971819. PMID 33205682 DOI: 10.1177/1352458520971819  1
2020 Ciplea AI, Datta P, Rewers-Felkins K, Baker T, Gold R, Hale TW, Hellwig K. Dimethyl fumarate transfer into human milk. Therapeutic Advances in Neurological Disorders. 13: 1756286420968414. PMID 33193814 DOI: 10.1177/1756286420968414  1
2020 Haase S, Wilck N, Haghikia A, Gold R, Mueller DN, Linker RA. The role of the gut microbiota and microbial metabolites in neuroinflammation. European Journal of Immunology. PMID 33188704 DOI: 10.1002/eji.201847807  1
2020 Fisse AL, Pitarokoili K, Leppert D, Motte J, Pedreiturria X, Kappos L, Gold R, Kuhle J, Yoon MS. Serum neurofilament light chain as outcome marker for intensive care unit patients. Journal of Neurology. PMID 33098034 DOI: 10.1007/s00415-020-10277-9  1
2020 Kinner M, Prehn C, Schneider R, Schroeder C, Kolb E, Gold R, Hoepner R, Chan A. Course of neuropsychological impairment during Natalizumab associated progressive multifocal leukoencephalopathy. European Journal of Neurology. PMID 33085811 DOI: 10.1111/ene.14604  1
2020 Comi G, Freedman MS, Meca-Lallana JE, Vermersch P, Kim BJ, Parajeles A, Edwards KR, Gold R, Korideck H, Chavin J, Poole EM, Coyle PK. Prior treatment status: impact on the efficacy and safety of teriflunomide in multiple sclerosis. Bmc Neurology. 20: 364. PMID 33023488 DOI: 10.1186/s12883-020-01937-4  1
2020 Richter D, Hegelmaier T, Schneider-Gold C, Gold R, Faissner S. Delayed Diagnosis of Anti-Hu Antibodies in a Young Patient With Cerebellar Atrophy. Pediatric Neurology. 111: 27-29. PMID 32951652 DOI: 10.1016/J.Pediatrneurol.2020.06.009  1
2020 Kühn E, Averdunk P, Huckemann S, Müller K, Biesalski AS, Hof Zum Berge F, Motte J, Fisse AL, Schneider-Gold C, Gold R, Pitarokoili K, Tönges L. Correlates of polyneuropathy in Parkinson's disease. Annals of Clinical and Translational Neurology. 7: 1898-1907. PMID 32940017 DOI: 10.1002/Acn3.51182  1
2020 Gold R, Giovannoni G, Phillips T, Bar-Or A, Fox RJ, Chen C, Miller C, Branco F. Revue Neurologique. 176: S126-S127. PMID 32906298 DOI: 10.1016/J.Neurol.2020.01.347  1
2020 Gold R, Montalban X, Haghikia A. Multiple sclerosis and nutrition: back to the future? Therapeutic Advances in Neurological Disorders. 13: 1756286420936165. PMID 32863887 DOI: 10.1177/1756286420936165  1
2020 Grüter T, Motte J, Fisse AL, Bulut Y, Köse N, Athanasopoulos D, Otto S, Yoon MS, Schneider-Gold C, Gold R, Pitarokoili K. Pathological spontaneous activity as a prognostic marker in chronic inflammatory demyelinating polyneuropathy. European Journal of Neurology. PMID 32794258 DOI: 10.1111/Ene.14476  1
2020 Wurm H, Attfield K, Iversen AK, Gold R, Fugger L, Haghikia A. Recovery from COVID-19 in a B-cell-depleted multiple sclerosis patient. Multiple Sclerosis (Houndmills, Basingstoke, England). 1352458520943791. PMID 32762494 DOI: 10.1177/1352458520943791  1
2020 Zella MAS, Bartig D, Herrmann L, Respondek G, Höglinger G, Gold R, Woitalla D, Krogias C, Tönges L. Hospitalization Rates and Comorbidities in Patients with Progressive Supranuclear Palsy in Germany from 2010 to 2017. Journal of Clinical Medicine. 9. PMID 32751888 DOI: 10.3390/Jcm9082454  1
2020 Gasperi C, Andlauer TFM, Keating A, Knier B, Klein A, Pernpeintner V, Lichtner P, Gold R, Zipp F, Then Bergh F, Stangel M, Tumani H, Wildemann B, Wiendl H, Bayas A, et al. Genetic determinants of the humoral immune response in MS. Neurology(R) Neuroimmunology & Neuroinflammation. 7. PMID 32675288 DOI: 10.1212/Nxi.0000000000000827  1
2020 Waldera-Lupa DM, Poschmann G, Kirchgaessler N, Etemad-Parishanzadeh O, Baberg F, Brocksieper M, Seidel S, Kowalski T, Brunn A, Haghikia A, Gold R, Stefanski A, Deckert M, Schlegel U, Stühler K. A Multiplex Assay for the Stratification of Patients with Primary Central Nervous System Lymphoma Using Targeted Mass Spectrometry. Cancers. 12. PMID 32610669 DOI: 10.3390/Cancers12071732  1
2020 Hartelt E, Scherbaum R, Kinkel M, Gold R, Muhlack S, Tönges L. Parkinson's Disease Multimodal Complex Treatment (PD-MCT): Analysis of Therapeutic Effects and Predictors for Improvement. Journal of Clinical Medicine. 9. PMID 32560079 DOI: 10.3390/Jcm9061874  1
2020 Gamber D, Motte J, Kerasnoudis A, Yoon MS, Gold R, Pitarokoili K, Fisse AL. High-Resolution Nerve Ultrasound to Assess Nerve Echogenicity, Fascicular Count, and Cross-Sectional Area Using Semiautomated Analysis. Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging. PMID 32521091 DOI: 10.1111/Jon.12717  1
2020 Datta P, Ciplea AI, Rewers-Felkins K, Baker T, Gold R, Hale TW, Hellwig K. Cladribine transfer into human milk: A case report. Multiple Sclerosis (Houndmills, Basingstoke, England). 1352458520912173. PMID 32507055 DOI: 10.1177/1352458520912173  1
2020 Schwake C, Hellwig K, Gold R, Ayzenberg I. Reader response: Comparison of the Response to Rituximab between Myelin Oligodendrocyte Glycoprotein and Aquaporin-4 Antibody Diseases. Annals of Neurology. PMID 32495967 DOI: 10.1002/Ana.25805  1
2020 Ostendorf F, Metzdorf J, Gold R, Haghikia A, Tönges L. Propionic Acid and Fasudil as Treatment Against Rotenone Toxicity in an In Vitro Model of Parkinson's Disease. Molecules (Basel, Switzerland). 25. PMID 32481507 DOI: 10.3390/Molecules25112502  1
2020 Bittner S, Steffen F, Uphaus T, Muthuraman M, Fleischer V, Salmen A, Luessi F, Berthele A, Klotz L, Meuth SG, Bayas A, Paul F, Hartung HP, Linker R, Heesen C, ... ... Gold R, et al. Clinical implications of serum neurofilament in newly diagnosed MS patients: A longitudinal multicentre cohort study. Ebiomedicine. 56: 102807. PMID 32460167 DOI: 10.1016/J.Ebiom.2020.102807  1
2020 Gold R, Radue EW, Giovannoni G, Selmaj K, Havrdova EK, Montalban X, Stefoski D, Sprenger T, Robinson RR, Fam S, Smith J, Chalkias S, Giannattasio G, Lima G, Castro-Borrero W. Long-term safety and efficacy of daclizumab beta in relapsing-remitting multiple sclerosis: 6-year results from the SELECTED open-label extension study. Journal of Neurology. PMID 32451615 DOI: 10.1007/S00415-020-09835-Y  1
2020 Grüter T, Behrendt V, Bien CI, Gold R, Ayzenberg I. Early immunotherapy is highly effective in IgG1/IgG4 positive IgLON5 disease. Journal of Neurology. PMID 32444985 DOI: 10.1007/S00415-020-09924-Y  1
2020 Ciplea AI, Langer-Gould A, Stahl A, Thiel S, Queisser-Wahrendorf A, Gold R, Hellwig K. Safety of potential breast milk exposure to IFN-β or glatiramer acetate: One-year infant outcomes. Neurology(R) Neuroimmunology & Neuroinflammation. 7. PMID 32434802 DOI: 10.1212/Nxi.0000000000000757  1
2020 Athanasopoulos D, Motte J, Fisse AL, Grueter T, Trampe N, Sturm D, Tegenthoff M, Sgodzai M, Klimas R, Querol L, Gold R, Pitarokoili K. Longitudinal study on nerve ultrasound and corneal confocal microscopy in NF155 paranodopathy. Annals of Clinical and Translational Neurology. PMID 32432402 DOI: 10.1002/Acn3.51061  1
2020 Gold R, Arnold DL, Bar-Or A, Fox RJ, Kappos L, Chen C, Parks B, Miller C. Safety and efficacy of delayed-release dimethyl fumarate in patients with relapsing-remitting multiple sclerosis: 9 years' follow-up of DEFINE, CONFIRM, and ENDORSE. Therapeutic Advances in Neurological Disorders. 13: 1756286420915005. PMID 32426039 DOI: 10.1177/1756286420915005  1
2020 Grüter T, Blusch A, Motte J, Sgodzai M, Bachir H, Klimas R, Ambrosius B, Gold R, Ellrichmann G, Pitarokoili K. Immunomodulatory and anti-oxidative effect of the direct TRPV1 receptor agonist capsaicin on Schwann cells. Journal of Neuroinflammation. 17: 145. PMID 32375895 DOI: 10.1186/S12974-020-01821-5  1
2020 Abrahamyan S, Eberspächer B, Hoshi MM, Aly L, Luessi F, Groppa S, Klotz L, Meuth SG, Schroeder C, Grüter T, Tackenberg B, Paul F, Then-Bergh F, Kümpfel T, Weber F, ... ... Gold R, et al. Complete Epstein-Barr virus seropositivity in a large cohort of patients with early multiple sclerosis. Journal of Neurology, Neurosurgery, and Psychiatry. PMID 32371533 DOI: 10.1136/Jnnp-2020-322941  1
2020 Engel S, Graetz C, Salmen A, Muthuraman M, Toenges G, Ambrosius B, Bayas A, Berthele A, Heesen C, Klotz L, Kümpfel T, Linker RA, Meuth SG, Paul F, Stangel M, ... ... Gold R, et al. Is ε4 associated with cognitive performance in early MS? Neurology(R) Neuroimmunology & Neuroinflammation. 7. PMID 32358224 DOI: 10.1212/Nxi.0000000000000728  1
2020 Ciplea AI, Langer-Gould A, de Vries A, Schaap T, Thiel S, Ringelstein M, Gold R, Hellwig K. Monoclonal antibody treatment during pregnancy and/or lactation in women with MS or neuromyelitis optica spectrum disorder. Neurology(R) Neuroimmunology & Neuroinflammation. 7. PMID 32327455 DOI: 10.1212/Nxi.0000000000000723  1
2020 Heitmann H, Haller B, Tiemann L, Mühlau M, Berthele A, Tölle TR, Salmen A, Ambrosius B, Bayas A, Asseyer S, Hartung HP, Heesen C, Stangel M, Wildemann B, Haars S, ... ... Gold R, et al. Longitudinal prevalence and determinants of pain in multiple sclerosis: results from the German National Multiple Sclerosis Cohort study. Pain. 161: 787-796. PMID 32197038 DOI: 10.1097/J.Pain.0000000000001767  1
2020 Duscha A, Gisevius B, Hirschberg S, Yissachar N, Stangl GI, Eilers E, Bader V, Haase S, Kaisler J, David C, Schneider R, Troisi R, Zent D, Hegelmaier T, Dokalis N, ... ... Gold R, et al. Propionic Acid Shapes the Multiple Sclerosis Disease Course by an Immunomodulatory Mechanism. Cell. PMID 32160527 DOI: 10.1016/J.Cell.2020.02.035  1
2020 Faissner S, Graz F, Reinehr S, Petrikowski L, Haupeltshofer S, Ceylan U, Stute G, Winklmeier S, Pache F, Paul F, Ruprecht K, Meinl E, Dick HB, Gold R, Kleiter I, et al. Binding patterns and functional properties of human antibodies to AQP4 and MOG on murine optic nerve and retina. Journal of Neuroimmunology. 342: 577194. PMID 32143071 DOI: 10.1016/J.Jneuroim.2020.577194  1
2020 Schroeder C, Katsanos AH, Richter D, Tsivgoulis G, Gold R, Krogias C. Quantification of Optic Nerve and Sheath Diameter by Transorbital Sonography: A Systematic Review and Metanalysis. Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging. PMID 32022367 DOI: 10.1111/Jon.12691  1
2020 Faissner S, Schwake C, Gotzmann M, Mügge A, Schmidt S, Gold R. Endocarditis following ocrelizumab in relapsing-remitting MS. Neurology(R) Neuroimmunology & Neuroinflammation. 7. PMID 32014890 DOI: 10.1212/Nxi.0000000000000680  1
2020 Arloth J, Eraslan G, Andlauer TFM, Martins J, Iurato S, Kühnel B, Waldenberger M, Frank J, Gold R, Hemmer B, Luessi F, Nischwitz S, Paul F, Wiendl H, Gieger C, et al. DeepWAS: Multivariate genotype-phenotype associations by directly integrating regulatory information using deep learning. Plos Computational Biology. 16: e1007616. PMID 32012148 DOI: 10.1371/Journal.Pcbi.1007616  1
2020 Diem L, Daponte A, Findling O, Miclea A, Briner M, Salmen A, Gold R, Kilidireas C, Chan A, Evangelopoulos ME, Hoepner R. Dimethyl fumarate vs fingolimod following different pretreatments: A retrospective study. Neurology(R) Neuroimmunology & Neuroinflammation. 7. PMID 31937596 DOI: 10.1212/Nxi.0000000000000660  1
2020 Kruczek P, Bellenberg B, Lutz T, Schneider R, Ahlborn C, Gold R, Köster O, Lukas C. Developmental Venous Anomalies are More Common in Patients with Multiple Sclerosis and Clinically Isolated Syndrome : Coincidence or Relevant? Clinical Neuroradiology. PMID 31897504 DOI: 10.1007/S00062-019-00869-Y  1
2019 Ayzenberg I, Faissner S, Tomaske L, Richter D, Behrendt V, Gold R. General principles and escalation options of immunotherapy in autoantibody-associated disorders of the CNS. Neurological Research and Practice. 1: 32. PMID 33324898 DOI: 10.1186/s42466-019-0037-x  1
2019 Motte J, Fisse AL, Grüter T, Schneider R, Breuer T, Lücke T, Krueger S, Nguyen HP, Gold R, Ayzenberg I, Ellrichmann G. Novel variants in a patient with late-onset hyperprolinemia type II: diagnostic key for status epilepticus and lactic acidosis. Bmc Neurology. 19: 345. PMID 31884946 DOI: 10.1186/S12883-019-1583-0  1
2019 Richter D, Katsanos AH, Schroeder C, Tsivgoulis G, Paraskevas GP, Müller T, Alexandrov AV, Gold R, Tönges L, Krogias C. Lentiform Nucleus Hyperechogenicity in Parkinsonian Syndromes: A Systematic Review and Meta-Analysis with Consideration of Molecular Pathology. Cells. 9. PMID 31861253 DOI: 10.3390/Cells9010002  1
2019 Schroeder C, Katsanos AH, Ayzenberg I, Schwake C, Gahlen A, Tsivgoulis G, Voumvourakis K, Gold R, Krogias C. Atrophy of optic nerve detected by Transorbital Sonography in Patients with Demyelinating Diseases of CNS. European Journal of Neurology. PMID 31814240 DOI: 10.1111/Ene.14137  1
2019 Scherbaum R, Hartelt E, Kinkel M, Gold R, Muhlack S, Tönges L. Parkinson's Disease Multimodal Complex Treatment improves motor symptoms, depression and quality of life. Journal of Neurology. PMID 31797086 DOI: 10.1007/S00415-019-09657-7  1
2019 Haupeltshofer S, Leichsenring T, Berg S, Pedreiturria X, Joachim SC, Tischoff I, Otte JM, Bopp T, Fantini MC, Esser C, Willbold D, Gold R, Faissner S, Kleiter I. Smad7 in intestinal CD4 T cells determines autoimmunity in a spontaneous model of multiple sclerosis. Proceedings of the National Academy of Sciences of the United States of America. PMID 31796589 DOI: 10.1073/Pnas.1905955116  1
2019 Faissner S, Gold R. [New therapeutic approaches in progressive multiple sclerosis]. Fortschritte Der Neurologie-Psychiatrie. 87: 653-671. PMID 31783427 DOI: 10.1055/A-0880-0073  1
2019 Schneider R, Genç E, Ahlborn C, Gold R, Lukas C, Bellenberg B. Temporal Dynamics of Diffusion Metrics in Early Multiple Sclerosis and Clinically Isolated Syndrome: A 2-Year Follow-Up Tract-Based Spatial Statistics Study. Frontiers in Neurology. 10: 1165. PMID 31749760 DOI: 10.3389/Fneur.2019.01165  1
2019 Grüter T, Ott A, Meyer W, Jarius S, Kinner M, Motte J, Pitarokoili K, Gold R, Komorowski L, Ayzenberg I. Effects of IVIg treatment on autoantibody testing in neurological patients: marked reduction in sensitivity but reliable specificity. Journal of Neurology. PMID 31728710 DOI: 10.1007/S00415-019-09614-4  1
2019 Schneider R, Brüne M, Breuer TG, Börnke C, Gold R, Juckel G. Early Multidisciplinary Intensive-care Therapy can Improve Outcome of Severe Anti-NMDA-receptor Encephalitis Presenting with Extreme Delta Brush. Translational Neuroscience. 10: 241-243. PMID 31637048 DOI: 10.1515/tnsci-2019-0039  1
2019 Faissner S, Gold R. Progressive multiple sclerosis: latest therapeutic developments and future directions. Therapeutic Advances in Neurological Disorders. 12: 1756286419878323. PMID 31598138 DOI: 10.1177/1756286419878323  1
2019 Kramer S, Haghikia A, Bang C, Scherf K, Pfanne A, Duscha A, Kaisler J, Gisevius B, Gold R, Thum T, Haghikia A. Elevated levels of miR-181c and miR-633 in the CSF of patients with MS: A validation study. Neurology(R) Neuroimmunology & Neuroinflammation. 6: e623. PMID 31575652 DOI: 10.1212/Nxi.0000000000000623  1
2019 Pitarokoili K, Bachir H, Sgodzai M, Grüter T, Haupeltshofer S, Duscha A, Pedreiturria X, Motte J, Gold R. Induction of Regulatory Properties in the Intestinal Immune System by Dimethyl Fumarate in Lewis Rat Experimental Autoimmune Neuritis. Frontiers in Immunology. 10: 2132. PMID 31552056 DOI: 10.3389/Fimmu.2019.02132  1
2019 Motte J, Kneiphof J, Straßburger-Krogias K, Pitarokoili K, Fisse AL, Kappos L, Gold R. Hereditary defect of cobalamin metabolism with adolescence onset resembling multiple sclerosis: 41-year follow up in two cases. Therapeutic Advances in Neurological Disorders. 12: 1756286419872115. PMID 31489032 DOI: 10.1177/1756286419872115  1
2019 Ayzenberg I, Ellrichmann G, Schroeder C, Tönges L, Klasing A, Pappa V, Brück W, Gold R. Brainstem Encephalitis With Low-Titer Acetylcholine Receptor Antibodies Mimicking Myasthenia Gravis. Frontiers in Neurology. 10: 829. PMID 31428040 DOI: 10.3389/Fneur.2019.00829  1
2019 Faissner S, Plemel JR, Gold R, Yong VW. Progressive multiple sclerosis: from pathophysiology to therapeutic strategies. Nature Reviews. Drug Discovery. PMID 31399729 DOI: 10.1038/S41573-019-0035-2  1
2019 Sinnecker T, Hadisurya J, Schneider-Hohendorf T, Schwab N, Wrede K, Gembruch O, Gold R, Hellwig K, Pilgram-Pastor S, Adams O, Albrecht P, Hartung HP, Aktas O, Kraemer M. Extensive immune reconstitution inflammatory syndrome in Fingolimod-associated PML: a case report with 7 Tesla MRI data. Bmc Neurology. 19: 190. PMID 31399069 DOI: 10.1186/S12883-019-1407-2  1
2019 Pitarokoili K, Gold R. Heterogeneous GBS course requires standardized guidelines. Nature Reviews. Neurology. PMID 31358946 DOI: 10.1038/S41582-019-0245-6  1
2019 Metzdorf J, Hobloss Z, Schlevogt S, Ayzenberg I, Stahlke S, Pedreiturria X, Haupeltshofer S, Gold R, Tönges L, Kleiter I. Fingolimod for Irradiation-Induced Neurodegeneration. Frontiers in Neuroscience. 13: 699. PMID 31354410 DOI: 10.3389/Fnins.2019.00699  1
2019 Bittner S, Engel S, Lange C, Weber MS, Haghikia A, Luessi F, Korn T, Klotz L, Bayas A, Paul F, Heesen C, Stangel M, Wildemann B, Bergh FT, Tackenberg B, ... ... Gold R, et al. [Diagnostics and treatment of tuberculosis under immunotherapy for multiple sclerosis : Current status and recommendations in Germany]. Der Nervenarzt. PMID 31297574 DOI: 10.1007/S00115-019-0760-0  1
2019 Pitarokoili K, Sturm D, Labedi A, Greiner T, Eitner L, Kumowski N, Enax-Krumova EK, Fisse AL, Maier C, Gold R, Tegenthoff M, Schmidt-Wilcke T, Yoon MS. Neuroimaging markers of clinical progression in chronic inflammatory demyelinating polyradiculoneuropathy. Therapeutic Advances in Neurological Disorders. 12: 1756286419855485. PMID 31244899 DOI: 10.1177/1756286419855485  1
2019 Richter D, Bartig D, Jost W, Jörges C, Stumpe B, Gold R, Krogias C, Tönges L. Dynamics of device-based treatments for Parkinson's disease in Germany from 2010 to 2017: application of continuous subcutaneous apomorphine, levodopa-carbidopa intestinal gel, and deep brain stimulation. Journal of Neural Transmission (Vienna, Austria : 1996). PMID 31222604 DOI: 10.1007/S00702-019-02034-8  1
2019 Ambrosius B, Gold R, Chan A, Faissner S. Antineuroinflammatory drugs in HIV-associated neurocognitive disorders as potential therapy. Neurology(R) Neuroimmunology & Neuroinflammation. 6: e551. PMID 31119186 DOI: 10.1212/Nxi.0000000000000551  1
2019 Nakahara J, Tomaske L, Kume K, Takata T, Kamada M, Deguchi K, Kufukihara K, Schneider R, Gold R, Ayzenberg I. Three cases of non-carryover fingolimod-PML: Is the risk in Japan increased? Neurology(R) Neuroimmunology & Neuroinflammation. 6: e559. PMID 31044147 DOI: 10.1212/Nxi.0000000000000559  1
2019 Gasperi C, Salmen A, Antony G, Bayas A, Heesen C, Kümpfel T, Linker RA, Paul F, Stangel M, Tackenberg B, Bergh FT, Warnke C, Weber F, Wiendl H, Wildemann B, ... ... Gold R, et al. Association of Intrathecal Immunoglobulin G Synthesis With Disability Worsening in Multiple Sclerosis. Jama Neurology. PMID 31034002 DOI: 10.1001/Jamaneurol.2019.0905  1
2019 Hoepner R, Bagnoud M, Pistor M, Salmen A, Briner M, Synn H, Schrewe L, Guse K, Ahmadi F, Demir S, Laverick L, Gresle M, Worley P, Reichardt HM, Butzkueven H, ... Gold R, et al. Vitamin D increases glucocorticoid efficacy via inhibition of mTORC1 in experimental models of multiple sclerosis. Acta Neuropathologica. PMID 31030237 DOI: 10.1007/S00401-019-02018-8  1
2019 Coyle PK, Khatri B, Edwards KR, Meca-Lallana JE, Cavalier S, Rufi P, Benamor M, Poole EM, Robinson M, Gold R. Teriflunomide real-world evidence: Global differences in the phase 4 Teri-PRO study. Multiple Sclerosis and Related Disorders. 31: 157-164. PMID 31005729 DOI: 10.1016/J.Msard.2019.03.022  1
2019 Krogias C, Christou I, Tsivgoulis G, Koutroulou I, Schroeder C, Lantinioti C, Richter D, Karapanayiotides T, Haghikia A, Gold R, Voumvourakis K. Functional Neurosonology Reveals Impaired Cerebrovascular Reactivity in Multiple Sclerosis. Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging. PMID 30990241 DOI: 10.1111/Jon.12617  1
2019 Masuda T, Sankowski R, Staszewski O, Böttcher C, Amann L, Scheiwe C, Sagar, Nessler S, Kunz P, van Loo G, Coenen VA, Reinacher PC, Michel A, Sure U, Gold R, et al. Author Correction: Spatial and temporal heterogeneity of mouse and human microglia at single-cell resolution. Nature. PMID 30918409 DOI: 10.1038/S41586-019-1045-2  1
2019 Mehta D, Miller C, Arnold DL, Bame E, Bar-Or A, Gold R, Hanna J, Kappos L, Liu S, Matta A, Phillips JT, Robertson D, von Hehn CA, Campbell J, Spach K, et al. Effect of dimethyl fumarate on lymphocytes in RRMS: Implications for clinical practice. Neurology. PMID 30918100 DOI: 10.1212/Wnl.0000000000007262  1
2019 van Well EM, Bader V, Patra M, Sánchez-Vicente A, Meschede J, Furthmann N, Schnack C, Blusch A, Longworth J, Petrasch-Parwez E, Mori K, Arzberger T, Trümbach D, Angersbach L, Showkat C, ... ... Gold R, et al. A protein quality control pathway regulated by linear ubiquitination. The Embo Journal. PMID 30886048 DOI: 10.15252/Embj.2018100730  1
2019 Ellrichmann G, Blusch A, Fatoba O, Brunner J, Reick C, Hayardeny L, Hayden M, Sehr D, Winklhofer KF, Saft C, Gold R. Author Correction: Laquinimod treatment in the R6/2 mouse model. Scientific Reports. 9: 4960. PMID 30874566 DOI: 10.1038/S41598-018-37926-4  1
2019 Vohl K, Duscha A, Gisevius B, Kaisler J, Gold R, Haghikia A. Predictors for Therapy Response to Intrathecal Corticosteroid Therapy in Multiple Sclerosis. Frontiers in Neurology. 10: 132. PMID 30853935 DOI: 10.3389/Fneur.2019.00132  1
2019 Pitarokoili K, Sgodzai M, Grüter T, Bachir H, Motte J, Ambrosius B, Pedreiturria X, Yoon MS, Gold R. Intrathecal triamcinolone acetonide exerts anti-inflammatory effects on Lewis rat experimental autoimmune neuritis and direct anti-oxidative effects on Schwann cells. Journal of Neuroinflammation. 16: 58. PMID 30851725 DOI: 10.1186/S12974-019-1445-0  1
2019 Dalla Costa G, Martinelli V, Moiola L, Sangalli F, Colombo B, Finardi A, Cinque P, Kolb EM, Haghikia A, Gold R, Furlan R, Comi G. Serum neurofilaments increase at PML onset in natalizumab-treated MS patients. Annals of Neurology. PMID 30761586 DOI: 10.1002/Ana.25437  1
2019 Masuda T, Sankowski R, Staszewski O, Böttcher C, Amann L, Scheiwe C, Nessler S, Kunz P, van Loo G, Coenen VA, Reinacher PC, Michel A, Sure U, Gold R, Priller J, et al. Spatial and temporal heterogeneity of mouse and human microglia at single-cell resolution. Nature. PMID 30760929 DOI: 10.1038/S41586-019-0924-X  1
2019 Richter D, Bartig D, Muhlack S, Hartelt E, Scherbaum R, Katsanos AH, Müller T, Jost W, Ebersbach G, Gold R, Krogias C, Tönges L. Dynamics of Parkinson's Disease Multimodal Complex Treatment in Germany from 2010⁻2016: Patient Characteristics, Access to Treatment, and Formation of Regional Centers. Cells. 8. PMID 30754730 DOI: 10.3390/Cells8020151  1
2019 Zella MAS, Metzdorf J, Ostendorf F, Maass F, Muhlack S, Gold R, Haghikia A, Tönges L. Novel Immunotherapeutic Approaches to Target Alpha-Synuclein and Related Neuroinflammation in Parkinson's Disease. Cells. 8. PMID 30708997 DOI: 10.3390/Cells8020105  1
2019 Pesch B, Casjens S, Woitalla D, Dharmadhikari S, Edmondson DA, Zella MAS, Lehnert M, Lotz A, Herrmann L, Muhlack S, Kraus P, Yeh CL, Glaubitz B, Schmidt-Wilcke T, Gold R, et al. Impairment of Motor Function Correlates with Neurometabolite and Brain Iron Alterations in Parkinson's Disease. Cells. 8. PMID 30699914 DOI: 10.3390/Cells8020096  1
2019 Chan A, Fox RJ, Bar-Or A, Chen C, Fam S, Gold R, Hanna J, Mehta D, Phillips JT. 159 Delayed-release dimethyl fumarate–associated lymphopenia Journal of Neurology, Neurosurgery, and Psychiatry. 90. DOI: 10.1136/Jnnp-2019-Abn-2.146  1
2019 Chan A, Fox RJ, Bar-Or A, Chen C, Fam S, Gold R, Hanna J, Mehta D, Phillips T, Yang L, Miller C. Delayed-release Dimethyl Fumarate-associated Lymphopenia: On-treatment and Post-treatment Implications Revue Neurologique. 175. DOI: 10.1016/J.Neurol.2019.01.266  1
2019 Gold R, Giovannoni G, Phillips T, Bar-Or A, Fox RJ, Chen C, Miller C. Delayed-release Dimethyl Fumarate demonstrates sustained efficacy over nine years in newly diagnosed patients with relapsing-remitting multiple Sclerosis Revue Neurologique. 175. DOI: 10.1016/J.Neurol.2019.01.263  1
2019 Sgodzai M, Bachir H, Klimas R, Motte J, Grüter T, Pedreiturria X, Gold R, Pitarokoili K. P59 Novel approaches to establish transgenic T-cell-receptor experimental autoimmune neuritis in mice resulted in proximal dominant clinical impairments Clinical Neurophysiology. 130. DOI: 10.1016/J.Clinph.2019.04.702  1
2019 Fisse AL, Pitarokoili K, Gold R, Yoon MS. P39 High resolution nerve ultrasound (HRUS) in criticall illness polyneuropathy (CIP) Clinical Neurophysiology. 130. DOI: 10.1016/J.Clinph.2019.04.691  1
2018 Demir S, Pitarokoili K, Linker R, Gold R. Immune cell derived BDNF does not mediate neuroprotection of the murine anti-CD52 antibody in a chronic autoimmune mouse model. Journal of Neuroimmunology. 328: 78-85. PMID 30623801 DOI: 10.1016/J.Jneuroim.2018.12.010  1
2018 Fisse AL, Pitarokoili K, Motte J, Gamber D, Kerasnoudis A, Gold R, Yoon MS. Nerve echogenicity and intranerve CSA variability in high-resolution nerve ultrasound (HRUS) in chronic inflammatory demyelinating polyneuropathy (CIDP). Journal of Neurology. PMID 30554264 DOI: 10.1007/S00415-018-9158-3  1
2018 Yoon MS, Pitarokoili K, Sturm D, Haghikia A, Gold R, Fisse AL. Treatment of an acute motor and sensory axonal neuropathy with propionate in a 33-year-old male. Therapeutic Advances in Neurological Disorders. 11: 1756286418809580. PMID 30542375 DOI: 10.1177/1756286418809580  1
2018 Zella SMA, Metzdorf J, Ciftci E, Ostendorf F, Muhlack S, Gold R, Tönges L. Emerging Immunotherapies for Parkinson Disease. Neurology and Therapy. PMID 30539376 DOI: 10.1007/S40120-018-0122-Z  1
2018 Johnen A, Bürkner PC, Landmeyer NC, Ambrosius B, Calabrese P, Motte J, Hessler N, Antony G, König IR, Klotz L, Hoshi MM, Aly L, Groppa S, Luessi F, Paul F, ... ... Gold R, et al. Can we predict cognitive decline after initial diagnosis of multiple sclerosis? Results from the German National early MS cohort (KKNMS). Journal of Neurology. PMID 30515631 DOI: 10.1007/S00415-018-9142-Y  1
2018 Classen G, Classen C, Bernasconi C, Brandt C, Gold R, Chan A, Hoepner R. Quantitative electroencephalography supports diagnosis of natalizumab-associated progressive multifocal leukoencephalopathy. Journal of Neurovirology. PMID 30414049 DOI: 10.1007/S13365-018-0689-2  1
2018 Fisse AL, Pitarokoili K, Trampe N, Motte J, Kerasnoudis A, Gold R, Yoon MS. Clinical, Sonographic, and Electrophysiologic Longitudinal Features of Chronic Inflammatory Demyelinating Polyneuropathy. Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging. PMID 30407676 DOI: 10.1111/Jon.12579  1
2018 Zella S, Kneiphof J, Haghikia A, Gold R, Woitalla D, Thöne J. Successful therapy with rituximab in three patients with probable neurosarcoidosis. Therapeutic Advances in Neurological Disorders. 11: 1756286418805732. PMID 30386436 DOI: 10.1177/1756286418805732  1
2018 Ellrichmann G, Bolz J, Peschke M, Duscha A, Hellwig K, Lee DH, Linker RA, Gold R, Haghikia A. Peripheral CD19 B-cell counts and infusion intervals as a surrogate for long-term B-cell depleting therapy in multiple sclerosis and neuromyelitis optica/neuromyelitis optica spectrum disorders. Journal of Neurology. PMID 30377816 DOI: 10.1007/S00415-018-9092-4  1
2018 Zella MAS, May C, Müller T, Ahrens M, Tönges L, Gold R, Marcus K, Woitalla D. Landscape of pain in Parkinson's disease: impact of gender differences. Neurological Research. 1-11. PMID 30311863 DOI: 10.1080/01616412.2018.1531208  1
2018 Coyle PK, Khatri B, Edwards KR, Meca-Lallana JE, Cavalier S, Rufi P, Benamor M, Thangavelu K, Robinson M, Gold R. Patient-reported outcomes in patients with relapsing forms of MS switching to teriflunomide from other disease-modifying therapies: Results from the global Phase 4 Teri-PRO study in routine clinical practice. Multiple Sclerosis and Related Disorders. 26: 211-218. PMID 30273841 DOI: 10.1016/J.Msard.2018.09.017  1
2018 Pitarokoili K, Höffken N, Lönneker N, Fisse AL, Trampe N, Gold R, Reinacher-Schick A, Yoon MS. Prospective Study of the Clinical, Electrophysiologic, and Sonographic Characteristics of Oxaliplatin-Induced Neuropathy. Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging. PMID 30198601 DOI: 10.1111/Jon.12557  1
2018 Richter D, Woitalla D, Muhlack S, Gold R, Tönges L, Krogias C. Brainstem Raphe Alterations in TCS: A Biomarker for Depression and Apathy in Parkinson's Disease Patients. Frontiers in Neurology. 9: 645. PMID 30131761 DOI: 10.3389/Fneur.2018.00645  1
2018 Motte J, Gold R, Krogias C. Monitoring of structural changes in the course of acute compressive radial neuropathies by means of high resolution nerve ultrasound. Journal of the Neurological Sciences. 391: 45-47. PMID 30103969 DOI: 10.1016/J.Jns.2018.05.021  1
2018 Grüter T, Ayzenberg I, Gahlen A, Kneiphof J, Gold R, Kleiter I. Flaccid paralysis in neuromyelitis optica: An atypical presentation with possible involvement of the peripheral nervous system. Multiple Sclerosis and Related Disorders. 25: 83-86. PMID 30056360 DOI: 10.1016/J.Msard.2018.07.032  1
2018 Thöne J, Lichtenberg S, Stahl A, Pache F, Kleiter I, Ruprecht K, Gold R, Hellwig K. Ovarian Reserve in Women With Neuromyelitis Optica Spectrum Disorder. Frontiers in Neurology. 9: 446. PMID 29973905 DOI: 10.3389/Fneur.2018.00446  1
2018 Schroeder C, Back C, Koc Ü, Strassburger-Krogias K, Reinacher-Schick A, Gold R, Haghikia A. Breakthrough treatment with bortezomib for a patient with anti-NMDAR encephalitis. Clinical Neurology and Neurosurgery. 172: 24-26. PMID 29960102 DOI: 10.1016/J.Clineuro.2018.06.005  1
2018 Motte J, Kneiphof J, Straßburger-Krogias K, Klasing A, Adams O, Haghikia A, Gold R. Detection of JC virus archetype in cerebrospinal fluid in a MS patient with dimethylfumarate treatment without lymphopenia or signs of PML. Journal of Neurology. PMID 29948248 DOI: 10.1007/S00415-018-8931-7  1
2018 Hammer A, Waschbisch A, Kuhbandner K, Bayas A, Lee DH, Duscha A, Haghikia A, Gold R, Linker RA. The NRF2 pathway as potential biomarker for dimethyl fumarate treatment in multiple sclerosis. Annals of Clinical and Translational Neurology. 5: 668-676. PMID 29928650 DOI: 10.1002/Acn3.553  1
2018 Kular L, Liu Y, Ruhrmann S, Zheleznyakova G, Marabita F, Gomez-Cabrero D, James T, Ewing E, Lindén M, Górnikiewicz B, Aeinehband S, Stridh P, Link J, Andlauer TFM, Gasperi C, ... ... Gold R, et al. DNA methylation as a mediator of HLA-DRB1*15:01 and a protective variant in multiple sclerosis. Nature Communications. 9: 2397. PMID 29921915 DOI: 10.1038/S41467-018-04732-5  1
2018 Wilmes AT, Reinehr S, Kühn S, Pedreiturria X, Petrikowski L, Faissner S, Ayzenberg I, Stute G, Gold R, Dick HB, Kleiter I, Joachim SC. Laquinimod protects the optic nerve and retina in an experimental autoimmune encephalomyelitis model. Journal of Neuroinflammation. 15: 183. PMID 29903027 DOI: 10.1186/S12974-018-1208-3  1
2018 Faissner S, Gold R. Correction to: Efficacy and Safety of the Newer Multiple Sclerosis Drugs Approved Since 2010. Cns Drugs. 32: 469-471. PMID 29796978 DOI: 10.1007/S40263-018-0524-6  1
2018 Pitarokoili K, Fels M, Kerasnoudis A, Toenges L, Gold R, Yoon MS. High-Resolution Nerve Ultrasound and Electrophysiological Findings in Restless Legs Syndrome. Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging. PMID 29749662 DOI: 10.1111/Jon.12520  1
2018 Gold R, Schlegel E, Elias-Hamp B, Albert C, Schmidt S, Tackenberg B, Xiao J, Schaak T, Salmen HC. Incidence and mitigation of gastrointestinal events in patients with relapsing-remitting multiple sclerosis receiving delayed-release dimethyl fumarate: a German phase IV study (TOLERATE). Therapeutic Advances in Neurological Disorders. 11: 1756286418768775. PMID 29707040 DOI: 10.1177/1756286418768775  1
2018 Huhn K, Bayas A, Doerck S, Frank B, Gerbershagen K, Hellwig K, Kallmann B, Kleinschnitz C, Kleiter I, Lee DH, Limmroth V, Mäurer M, Meuth S, Rieckmann P, Ruck T, ... Gold R, et al. Alemtuzumab as rescue therapy in a cohort of 50 relapsing-remitting MS patients with breakthrough disease on fingolimod: a multi-center observational study. Journal of Neurology. PMID 29696498 DOI: 10.1007/S00415-018-8871-2  1
2018 Motte J, Ambrosius B, Grüter T, Bachir H, Sgodzai M, Pedreiturria X, Pitarokoili K, Gold R. Capsaicin-enriched diet ameliorates autoimmune neuritis in rats. Journal of Neuroinflammation. 15: 122. PMID 29690884 DOI: 10.1186/S12974-018-1165-X  1
2018 Faissner S, Gold R. Efficacy and Safety of the Newer Multiple Sclerosis Drugs Approved Since 2010. Cns Drugs. PMID 29600441 DOI: 10.1007/S40263-018-0488-6  1
2018 Kappos L, Bar-Or A, Cree BAC, Fox RJ, Giovannoni G, Gold R, Vermersch P, Arnold DL, Arnould S, Scherz T, Wolf C, Wallström E, Dahlke F. Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study. Lancet (London, England). PMID 29576505 DOI: 10.1016/S0140-6736(18)30475-6  1
2018 Pitarokoili K, Kronlage M, Bäumer P, Schwarz D, Gold R, Bendszus M, Yoon MS. High-resolution nerve ultrasound and magnetic resonance neurography as complementary neuroimaging tools for chronic inflammatory demyelinating polyneuropathy. Therapeutic Advances in Neurological Disorders. 11: 1756286418759974. PMID 29552093 DOI: 10.1177/1756286418759974  1
2018 Spicher C, Schneider R, Mönnings P, Schneider-Gold C, Kallenberg D, Cevik B, Lukas C, Gold R, Krogias C. Mechanical thrombectomy in a young stroke patient with Duchenne muscular dystrophy. Therapeutic Advances in Neurological Disorders. 11: 1756286418759188. PMID 29552091 DOI: 10.1177/1756286418759188  1
2018 Graetz C, Gröger A, Luessi F, Salmen A, Zöller D, Schultz J, Siller N, Fleischer V, Bellenberg B, Berthele A, Biberacher V, Havla J, Hecker M, Hohlfeld R, Infante-Duarte C, ... ... Gold R, et al. Association of smoking but not HLA-DRB1*15:01, APOE or body mass index with brain atrophy in early multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). 1352458518763541. PMID 29532745 DOI: 10.1177/1352458518763541  1
2018 Kita M, Fox RJ, Gold R, Giovannoni G, Phillips JT, Sarda SP, Kong J, Viglietta V, Sheikh SI, Okwuokenye M, Kappos L. Corrigendum to 'Effects of Delayed-Release Dimethyl Fumarate (DMF) on Health-Related Quality of Life in Patients With Relapsing-Remitting Multiple Sclerosis: An Integrated Analysis of the Phase 3 DEFINE and CONFIRM Studies: [Clinical Therapeutics 36 (2014) 1958-1971]. Clinical Therapeutics. PMID 29523369 DOI: 10.1016/J.Clinthera.2018.02.005  1
2018 von Bismarck O, Dankowski T, Ambrosius B, Hessler N, Antony G, Ziegler A, Hoshi MM, Aly L, Luessi F, Groppa S, Klotz L, Meuth SG, Tackenberg B, Stoppe M, Then Bergh F, ... ... Gold R, et al. Treatment choices and neuropsychological symptoms of a large cohort of early MS. Neurology(R) Neuroimmunology & Neuroinflammation. 5: e446. PMID 29511705 DOI: 10.1212/Nxi.0000000000000446  1
2018 Faissner S, Gold R. Oral Therapies for Multiple Sclerosis. Cold Spring Harbor Perspectives in Medicine. PMID 29500302 DOI: 10.1101/Cshperspect.A032011  1
2018 Faissner S, Gold R. Clinical commentary on 'Severe hypertriglyceridemia associated with teriflunomide in a patient with multiple sclerosis'. Multiple Sclerosis (Houndmills, Basingstoke, England). 1352458518761188. PMID 29473795 DOI: 10.1177/1352458518761188  1
2018 Montalban X, Gold R, Thompson AJ, Otero-Romero S, Amato MP, Chandraratna D, Clanet M, Comi G, Derfuss T, Fazekas F, Hartung HP, Havrdova E, Hemmer B, Kappos L, Liblau R, et al. ECTRIMS/EAN Guideline on the pharmacological treatment of people with multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). 1352458517751049. PMID 29353550 DOI: 10.1177/1352458517751049  1
2018 Montalban X, Gold R, Thompson AJ, Otero-Romero S, Amato MP, Chandraratna D, Clanet M, Comi G, Derfuss T, Fazekas F, Hartung HP, Havrdova E, Hemmer B, Kappos L, Liblau R, et al. ECTRIMS/EAN guideline on the pharmacological treatment of people with multiple sclerosis. European Journal of Neurology. PMID 29352526 DOI: 10.1111/Ene.13536  1
2018 Fatoba O, Kloster E, Reick C, Saft C, Gold R, Epplen JT, Arning L, Ellrichmann G. Activation of NPY-Y2 receptors ameliorates disease pathology in the R6/2 mouse and PC12 cell models of Huntington's disease. Experimental Neurology. PMID 29309751 DOI: 10.1016/J.Expneurol.2018.01.001  1
2018 Haase S, Haghikia A, Gold R, Linker RA. Dietary fatty acids and susceptibility to multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). 24: 12-16. PMID 29307296 DOI: 10.1177/1352458517737372  1
2018 Grüter T, Metz I, Gahlen A, Kneiphof J, Stork L, Brück W, Gold R, Kleiter I. Mitoxantrone treatment in a patient with multiple sclerosis and pattern III lesions Clinical and Experimental Neuroimmunology. 9: 169-172. DOI: 10.1111/Cen3.12466  1
2018 Gold R. Erstmalig europäische Leitlinien zur MS-Therapie Aktuelle Neurologie. 45: 5-6. DOI: 10.1055/S-0043-124577  0.01
2018 Pitarokoili K, Sgodzai M, Bachir H, Grüter T, Gold R. P95. Immunmodulatory effects of intrathecal administration of triamcinolone in experimental autoimmune neuritis model in lewis rats Clinical Neurophysiology. 129. DOI: 10.1016/J.Clinph.2018.04.717  1
2017 Hammer A, Waschbisch A, Knippertz I, Zinser E, Berg J, Jörg S, Kuhbandner K, David C, Pi J, Bayas A, Lee DH, Haghikia A, Gold R, Steinkasserer A, Linker RA. Role of Nuclear Factor (Erythroid-Derived 2)-Like 2 Signaling for Effects of Fumaric Acid Esters on Dendritic Cells. Frontiers in Immunology. 8: 1922. PMID 29312359 DOI: 10.3389/Fimmu.2017.01922  1
2017 Pitarokoili K, Gold R. Multiple sclerosis: Progressive multifocal leukoencephalopathy risk stratification. Nature Reviews. Neurology. PMID 29146954 DOI: 10.1038/Nrneurol.2017.161  1
2017 Pitarokoili K, Ambrosius B, Gold R. Lewis Rat Model of Experimental Autoimmune Encephalomyelitis. Current Protocols in Neuroscience. 81: 9.61.1-9.61.20. PMID 29058769 DOI: 10.1002/Cpns.36  1
2017 Rose JW, Giovannoni G, Wiendl H, Gold R, Havrdová E, Kappos L, Selmaj KW, Zhao J, Riester K, Tsao LC, Greenberg SJ. Consistent efficacy of daclizumab beta across patient demographic and disease activity subgroups in patients with relapsing-remitting multiple sclerosis. Multiple Sclerosis and Related Disorders. 17: 32-40. PMID 29055471 DOI: 10.1016/J.Msard.2017.06.006  1
2017 Coyle PK, Khatri B, Edwards KR, Meca-Lallana JE, Cavalier S, Rufi P, Benamor M, Brette S, Robinson M, Gold R. Patient-reported outcomes in relapsing forms of MS: Real-world, global treatment experience with teriflunomide from the Teri-PRO study. Multiple Sclerosis and Related Disorders. 17: 107-115. PMID 29055438 DOI: 10.1016/J.Msard.2017.07.006  1
2017 Schneider-Gold C, Reinacher-Schick A, Ellrichmann G, Gold R. Bortezomib in severe MuSK-antibody positive myasthenia gravis: first clinical experience. Therapeutic Advances in Neurological Disorders. 10: 339-341. PMID 28966662 DOI: 10.1177/1756285617721093  1
2017 Schneider R, Bellenberg B, Hoepner R, Ellrichmann G, Gold R, Lukas C. Insight into Metabolic (1)H-MRS Changes in Natalizumab Induced Progressive Multifocal Leukoencephalopathy Brain Lesions. Frontiers in Neurology. 8: 454. PMID 28928709 DOI: 10.3389/Fneur.2017.00454  1
2017 Plavina T, Muralidharan KK, Kuesters G, Mikol D, Evans K, Subramanyam M, Nestorov I, Chen Y, Dong Q, Ho PR, Amarante D, Adams A, De Sèze J, Fox R, Gold R, et al. Reversibility of the effects of natalizumab on peripheral immune cell dynamics in MS patients. Neurology. PMID 28916537 DOI: 10.1212/Wnl.0000000000004485  1
2017 Hammer A, Schliep A, Jörg S, Haghikia A, Gold R, Kleinewietfeld M, Müller DN, Linker RA. Impact of combined sodium chloride and saturated long-chain fatty acid challenge on the differentiation of T helper cells in neuroinflammation. Journal of Neuroinflammation. 14: 184. PMID 28899400 DOI: 10.1186/S12974-017-0954-Y  1
2017 Faissner S, Mahjoub Y, Mishra M, Haupeltshofer S, Hahn JN, Gold R, Koch M, Metz LM, Ben-Hur T, Yong VW. Unexpected additive effects of minocycline and hydroxychloroquine in models of multiple sclerosis: Prospective combination treatment for progressive disease? Multiple Sclerosis (Houndmills, Basingstoke, England). 1352458517728811. PMID 28857721 DOI: 10.1177/1352458517728811  1
2017 Pitarokoili K, Yoon MS, Kröger I, Reinacher-Schick A, Gold R, Schneider-Gold C. Severe refractory CIDP: a case series of 10 patients treated with bortezomib. Journal of Neurology. PMID 28836002 DOI: 10.1007/S00415-017-8599-4  1
2017 Fox RJ, Gold R, Phillips JT, Okwuokenye M, Zhang A, Marantz JL. Efficacy and Tolerability of Delayed-release Dimethyl Fumarate in Black, Hispanic, and Asian Patients with Relapsing-Remitting Multiple Sclerosis: Post Hoc Integrated Analysis of DEFINE and CONFIRM. Neurology and Therapy. PMID 28770420 DOI: 10.1007/S40120-017-0077-5  1
2017 Fernández Ó, Giovannoni G, Fox RJ, Gold R, Phillips JT, Potts J, Okwuokenye M, Marantz JL. Efficacy and Safety of Delayed-release Dimethyl Fumarate for Relapsing-Remitting Multiple Sclerosis in Prior Interferon Users: An Integrated Analysis of DEFINE and CONFIRM. Clinical Therapeutics. PMID 28751099 DOI: 10.1016/J.Clinthera.2017.06.012  1
2017 Pitarokoili K, Gold R. Dimethyl fumarate for patients with neuromyelitis optica spectrum disorder. Multiple Sclerosis (Houndmills, Basingstoke, England). 1352458517717090. PMID 28747147 DOI: 10.1177/1352458517717090  1
2017 Schroeder C, Schneider-Gold C, Behrendt V, Grüter T, Lukas C, Gold R, Krogias C. Unilateral right prosopometamorphopsia with positive "half-face-covering-test" after small occipitotemporal stroke. Journal of the Neurological Sciences. 379: 247-248. PMID 28716251 DOI: 10.1016/J.Jns.2017.06.025  1
2017 Ellrichmann G, Blusch A, Fatoba O, Brunner J, Hayardeny L, Hayden M, Sehr D, Winklhofer KF, Saft C, Gold R. Laquinimod treatment in the R6/2 mouse model. Scientific Reports. 7: 4947. PMID 28694434 DOI: 10.1038/S41598-017-04990-1  1
2017 Gahlen A, Trampe AK, Haupeltshofer S, Ringelstein M, Aktas O, Berthele A, Wildemann B, Gold R, Jarius S, Kleiter I. Aquaporin-4 antibodies in patients treated with natalizumab for suspected MS. Neurology(R) Neuroimmunology & Neuroinflammation. 4: e363. PMID 28642888 DOI: 10.1212/Nxi.0000000000000363  1
2017 Massa MG, David C, Jörg S, Berg J, Gisevius B, Hirschberg S, Linker RA, Gold R, Haghikia A. Testosterone Differentially Affects T Cells and Neurons in Murine and Human Models of Neuroinflammation and Neurodegeneration. The American Journal of Pathology. 187: 1613-1622. PMID 28634006 DOI: 10.1016/J.Ajpath.2017.03.006  1
2017 Kronlage M, Bäumer P, Pitarokoili K, Schwarz D, Schwehr V, Godel T, Heiland S, Gold R, Bendszus M, Yoon MS. Large coverage MR neurography in CIDP: diagnostic accuracy and electrophysiological correlation. Journal of Neurology. PMID 28620719 DOI: 10.1007/S00415-017-8543-7  1
2017 Pitarokoili K, Kohle F, Motte J, Fatoba O, Pedreiturria X, Gold R, Yoon MS. Anti-inflammatory and immunomodulatory potential of human immunoglobulin applied intrathecally in Lewis rat experimental autoimmune neuritis. Journal of Neuroimmunology. 309: 58-67. PMID 28601289 DOI: 10.1016/J.Jneuroim.2017.05.008  1
2017 Hagström IT, Schneider R, Bellenberg B, Salmen A, Weiler F, Köster O, Gold R, Lukas C. Relevance of early cervical cord volume loss in the disease evolution of clinically isolated syndrome and early multiple sclerosis: a 2-year follow-up study. Journal of Neurology. PMID 28600596 DOI: 10.1007/S00415-017-8537-5  1
2017 Popkirov S, Ayzenberg I, Hahn S, Bauer J, Denno Y, Rieckhoff N, Radzimski C, Hans VH, Berg S, Roghmann F, Noldus J, Bien CG, Skodda S, Wellmer J, Stöcker W, ... ... Gold R, et al. Rho-associated protein kinase 2 (ROCK2): a new target of autoimmunity in paraneoplastic encephalitis. Acta Neuropathologica Communications. 5: 40. PMID 28554330 DOI: 10.1186/S40478-017-0447-3  1
2017 Reiser M, Borte M, Huscher D, Baumann U, Pittrow D, Sommer C, Stangel M, Fasshauer M, Gold R, Hensel M. Management of patients with malignancies and secondary immunodeficiencies treated with immunoglobulins in clinical practice: long-term data of the SIGNS study. European Journal of Haematology. PMID 28467615 DOI: 10.1111/Ejh.12900  1
2017 Ambrosius B, Pitarokoili K, Schrewe L, Pedreiturria X, Motte J, Gold R. Fingolimod attenuates experimental autoimmune neuritis and contributes to Schwann cell-mediated axonal protection. Journal of Neuroinflammation. 14: 92. PMID 28446186 DOI: 10.1186/S12974-017-0864-Z  1
2017 Schneider R, Bellenberg B, Hoepner R, Kolb EM, Ellrichmann G, Haghikia A, Gold R, Lukas C. Metabolic profiles by 1H-magnetic resonance spectroscopy in natalizumab-associated post-PML lesions of multiple sclerosis patients who survived progressive multifocal leukoencephalopathy (PML). Plos One. 12: e0176415. PMID 28445498 DOI: 10.1371/Journal.Pone.0176415  1
2017 Richter D, Woitalla D, Muhlack S, Gold R, Tönges L, Krogias C. Coronal Transcranial Sonography and M-Mode Tremor Frequency Determination in Parkinson's Disease and Essential Tremor. Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging. PMID 28426143 DOI: 10.1111/Jon.12441  1
2017 Ellrichmann G, Gold R, Ayzenberg I, Yoon MS, Schneider-Gold C. Two years' long-term follow up in chronic inflammatory demyelinating polyradiculoneuropathy: efficacy of intravenous immunoglobulin treatment. Therapeutic Advances in Neurological Disorders. 10: 91-101. PMID 28382108 DOI: 10.1177/1756285616679369  1
2017 Thone J, Thiel S, Gold R, Hellwig K. Treatment of multiple sclerosis during pregnancy - safety considerations. Expert Opinion On Drug Safety. PMID 28333552 DOI: 10.1080/14740338.2017.1311321  1
2017 Havrdova E, Giovannoni G, Gold R, Fox RJ, Kappos L, Phillips JT, Okwuokenye M, Marantz JL. Effect of delayed-release dimethyl fumarate on no evidence of disease activity in relapsing-remitting multiple sclerosis: integrated analysis of the phase III DEFINE and CONFIRM studies. European Journal of Neurology. PMID 28328179 DOI: 10.1111/ene.13272  1
2017 Fisse AL, Straßburger-Krogias K, Gold R, Ellrichmann G. Recurrent trimethoprim-sulfamethoxazole-induced aseptic meningitis with associated ampicillin-induced myoclonic twitches
. International Journal of Clinical Pharmacology and Therapeutics. PMID 28291512 DOI: 10.5414/CP202957  1
2017 Ambrosius B, Faissner S, Guse K, von Lehe M, Grunwald T, Gold R, Grewe B, Chan A. Teriflunomide and monomethylfumarate target HIV-induced neuroinflammation and neurotoxicity. Journal of Neuroinflammation. 14: 51. PMID 28284222 DOI: 10.1186/S12974-017-0829-2  1
2017 Krogias C, Gold R, Schelle T, Böhm J, Junker A, Sure U, Uerschels AK. Teaching NeuroImages: Sonographic detection of intraneural perineurioma in therapy-refractory carpal tunnel syndrome. Neurology. 88: e85-e86. PMID 28265045 DOI: 10.1212/Wnl.0000000000003692  1
2017 Pitarokoili K, Hellwig K, Lukas C, Gold R. Successful pregnancy after natalizumab-associated progressive multifocal leukoencephalopathy in a patient with multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). 23: 483-486. PMID 28260421 DOI: 10.1177/1352458516678475  1
2017 Motte J, Kreitschmann-Andermahr I, Fisse AL, Börnke C, Schroeder C, Pitarokoili K, Müller O, Lukas C, van de Nes J, Buslei R, Gold R, Ayzenberg I. Trigemino-autonomic headache and Horner syndrome as a first sign of granulomatous hypophysitis. Neurology(R) Neuroimmunology & Neuroinflammation. 4: e332. PMID 28243612 DOI: 10.1212/Nxi.0000000000000332  1
2017 Wilhelms W, Bellenberg B, Köster O, Weiler F, Hoffmann R, Gold R, Saft C, Lukas C. Progressive spinal cord atrophy in manifest and premanifest Huntington's disease. Journal of Neurology, Neurosurgery, and Psychiatry. PMID 28209652 DOI: 10.1136/Jnnp-2016-315000  1
2017 Gopal S, Mikulskis A, Gold R, Fox RJ, Dawson KT, Amaravadi L. Evidence of activation of the Nrf2 pathway in multiple sclerosis patients treated with delayed-release dimethyl fumarate in the Phase 3 DEFINE and CONFIRM studies. Multiple Sclerosis (Houndmills, Basingstoke, England). 1352458517690617. PMID 28156185 DOI: 10.1177/1352458517690617  1
2017 Engler H, Brendt P, Wischermann J, Wegner A, Röhling R, Schoemberg T, Meyer U, Gold R, Peters J, Benson S, Schedlowski M. Selective increase of cerebrospinal fluid IL-6 during experimental systemic inflammation in humans: association with depressive symptoms. Molecular Psychiatry. PMID 28138158 DOI: 10.1038/Mp.2016.264  0.01
2017 Haghikia A, Dendrou CA, Schneider R, Grüter T, Postert T, Matzke M, Stephanik H, Fugger L, Gold R. Severe B-cell-mediated CNS disease secondary to alemtuzumab therapy. The Lancet. Neurology. 16: 104-106. PMID 28102146 DOI: 10.1016/S1474-4422(16)30382-9  1
2017 Coyle PK, Khatri B, Edwards KR, Cavalier S, Rufi P, Brette S, Kulkarni P, Gold R. PO153 Teri-pro patients switching to teriflunomide from prior dmt Journal of Neurology, Neurosurgery, and Psychiatry. 88. DOI: 10.1136/Jnnp-2017-Abn.182  1
2017 Ayzenberg I, Gold R, Kleiter I. Therapie der immunvermittelten paraneoplastischen neurologischen Erkrankungen Aktuelle Neurologie. 45: 200-211. DOI: 10.1055/S-0043-112741  1
2016 Giovannoni G, Gold R, Kappos L, Arnold DL, Bar-Or A, Marantz JL, Yang M, Lee A. Delayed-release dimethyl fumarate and disability assessed by the Multiple Sclerosis Functional Composite: Integrated analysis of DEFINE and CONFIRM. Multiple Sclerosis Journal - Experimental, Translational and Clinical. 2: 2055217316634111. PMID 28607719 DOI: 10.1177/2055217316634111  1
2016 Salmen A, von Ahsen N, Trampe AK, Hoepner R, Plavina T, Subramanyam M, Kuesters G, Gold R, Chan A. Longitudinal analyses of anti-JCV antibody index for risk assessment of progressive multifocal leukoencephalopathy. Multiple Sclerosis Journal - Experimental, Translational and Clinical. 2: 2055217316630008. PMID 28607714 DOI: 10.1177/2055217316630008  1
2016 Golla H, Ebke M, Rolke R, Lorenzl S, Nacimiento W, Thiekötter T, Fink GR, Gold R, Voltz R. [Integration of Palliative and Hospice Care Structures in the Care of Neurological Patients: Opinion of Chief Consultant Neurologists in Germany]. Fortschritte Der Neurologie-Psychiatrie. 84: 733-738. PMID 27951604 DOI: 10.1055/S-0042-119027  0.01
2016 Hammer A, Yang G, Friedrich J, Kovacs A, Lee DH, Grave K, Jörg S, Alenina N, Grosch J, Winkler J, Gold R, Bader M, Manzel A, Rump LC, Müller DN, et al. Role of the receptor Mas in macrophage-mediated inflammation in vivo. Proceedings of the National Academy of Sciences of the United States of America. PMID 27872279 DOI: 10.1073/Pnas.1612668113  1
2016 Kinner M, Hoepner R, Klotz P, Prehn C, Faissner S, Salmen A, Linker RA, Gold R, Chan A. Immunotherapy Improves Cognitive Function in Secondary Progressive Multiple Sclerosis. Cns Neuroscience & Therapeutics. PMID 27739247 DOI: 10.1111/Cns.12652  1
2016 Faissner S, Lukas C, Reinacher-Schick A, Tannapfel A, Gold R, Kleiter I. Amphiphysin-positive paraneoplastic myelitis and stiff-person syndrome. Neurology(R) Neuroimmunology & Neuroinflammation. 3: e285. PMID 27734022 DOI: 10.1212/Nxi.0000000000000285  1
2016 Haghikia A, Gold R. Active immunotherapy may delay disability in progressive MS. Journal of Neurology, Neurosurgery, and Psychiatry. PMID 27683917 DOI: 10.1136/Jnnp-2016-314377  1
2016 Giovannoni G, Kappos L, Gold R, Khatri BO, Selmaj K, Umans K, Greenberg SJ, Sweetser M, Elkins J, McCroskery P. Safety and tolerability profile of daclizumab in patients with relapsing-remitting multiple sclerosis: An integrated analysis of clinical studies. Multiple Sclerosis and Related Disorders. 9: 36-46. PMID 27645341 DOI: 10.1016/J.Msard.2016.05.010  1
2016 Berg J, Mahmoudjanlou Y, Duscha A, Massa MG, Thöne J, Esser C, Gold R, Haghikia A. The immunomodulatory effect of laquinimod in CNS autoimmunity is mediated by the aryl hydrocarbon receptor. Journal of Neuroimmunology. 298: 9-15. PMID 27609269 DOI: 10.1016/J.Jneuroim.2016.06.003  1
2016 Hoepner R, Kolb EM, Dahlhaus S, Hellwig K, Adams O, Kleiter I, Salmen A, Schneider R, Lukas C, Chan A, Berger JR, Gold R. Predictors of severity and functional outcome in natalizumab-associated progressive multifocal leukoencephalopathy. Multiple Sclerosis (Houndmills, Basingstoke, England). PMID 27600113 DOI: 10.1177/1352458516667241  1
2016 Reick C, Ellrichmann G, Tsai T, Lee DH, Wiese S, Gold R, Saft C, Linker RA. Expression of brain-derived neurotrophic factor in astrocytes - Beneficial effects of glatiramer acetate in the R6/2 and YAC128 mouse models of Huntington's disease. Experimental Neurology. PMID 27587303 DOI: 10.1016/J.Expneurol.2016.08.012  1
2016 Faissner S, Lukas C, Chan A, Gold R, Krogias C. "Punched nerve syndrome" as contributing factor for "Saturday night palsy". Journal of the Neurological Sciences. 368: 173-4. PMID 27538626 DOI: 10.1016/J.Jns.2016.07.012  1
2016 Behrendt V, Krogias C, Reinacher-Schick A, Gold R, Kleiter I. Bortezomib Treatment for Patients With Anti-N-Methyl-d-Aspartate Receptor Encephalitis. Jama Neurology. PMID 27533122 DOI: 10.1001/Jamaneurol.2016.2588  1
2016 Grüter T, Ayzenberg I, Gold R, Börnke C. Charles Bonnet syndrome successfully treated with levetiracetam. Journal of Neurology. 263: 1872-5. PMID 27485168 DOI: 10.1007/S00415-016-8240-Y  1
2016 Vermersch P, Smets L, Gold R. Conclusions: Calls to action for improving the life of MS patients and their families. Multiple Sclerosis (Houndmills, Basingstoke, England). 22: 71-7. PMID 27465617 DOI: 10.1177/1352458516650738  1
2016 Gold R, Toumi M, Meesen B, Fogarty E. The payer's perspective: What is the burden of MS and how should the patient's perspective be integrated in health technology assessment conducted for taking decisions on access to care and treatment? Multiple Sclerosis (Houndmills, Basingstoke, England). 22: 60-70. PMID 27465616 DOI: 10.1177/1352458516650743  1
2016 Vermersch P, Berger T, Gold R, Lukas C, Rovira A, Meesen B, Chard D, Comabella M, Palace J, Trojano M. The clinical perspective: How to personalise treatment in MS and how may biomarkers including imaging contribute to this? Multiple Sclerosis (Houndmills, Basingstoke, England). 22: 18-33. PMID 27465613 DOI: 10.1177/1352458516650739  1
2016 Vermersch P, Smets L, Gold R. Introduction: Do we need multi-stakeholder colloquia in MS? Multiple Sclerosis (Houndmills, Basingstoke, England). 22: 4-8. PMID 27465611 DOI: 10.1177/1352458516650740  1
2016 Gold R, Radue EW, Giovannoni G, Selmaj K, Havrdova E, Stefoski D, Sprenger T, Montalban X, Cohan S, Umans K, Greenberg SJ, Ozen G, Elkins J. Safety and efficacy of daclizumab in relapsing-remitting multiple sclerosis: 3-year results from the SELECTED open-label extension study. Bmc Neurology. 16: 117. PMID 27461166 DOI: 10.1186/S12883-016-0635-Y  1
2016 Décard BF, Thöne J, Haghikia A, Börnke C, Anders A, Lukas C, Gold R. Listeria rhombencephalitis mimicking a demyelinating event in an immunocompetent young patient. Multiple Sclerosis (Houndmills, Basingstoke, England). PMID 27430683 DOI: 10.1177/1352458516650522  1
2016 Gold R, Stefoski D, Selmaj K, Havrdova E, Hurst C, Holman J, Tornesi B, Akella S, McCroskery P. Pregnancy Experience: Nonclinical Studies and Pregnancy Outcomes in the Daclizumab Clinical Study Program. Neurology and Therapy. PMID 27411694 DOI: 10.1007/S40120-016-0048-2  1
2016 Ellrichmann G, Lukas C, Adamietz IA, Grunwald C, Schneider-Gold C, Gold R. [Radiation-Induced Radiculopathy with Paresis of the Neck and Autochthonous Back Muscles with Additional Myopathy]. Fortschritte Der Neurologie-Psychiatrie. 84: 363-7. PMID 27391986 DOI: 10.1055/s-0042-108195  1
2016 Andlauer TF, Buck D, Antony G, Bayas A, Bechmann L, Berthele A, Chan A, Gasperi C, Gold R, Graetz C, Haas J, Hecker M, Infante-Duarte C, Knop M, Kümpfel T, et al. Novel multiple sclerosis susceptibility loci implicated in epigenetic regulation. Science Advances. 2: e1501678. PMID 27386562 DOI: 10.1126/Sciadv.1501678  1
2016 Schneider-Gold C, Krenzer M, Klinker E, Mansouri-Thalegani B, Müllges W, Toyka KV, Gold R. Immunoadsorption versus plasma exchange versus combination for treatment of myasthenic deterioration. Therapeutic Advances in Neurological Disorders. 9: 297-303. PMID 27366236 DOI: 10.1177/1756285616637046  1
2016 Faissner S, Nikolayczik J, Chan A, Gold R, Yoon MS, Haghikia A. Immunoadsorption in patients with neuromyelitis optica spectrum disorder. Therapeutic Advances in Neurological Disorders. 9: 281-6. PMID 27366234 DOI: 10.1177/1756285616646332  1
2016 Fox RJ, Chan A, Gold R, Phillips JT, Selmaj K, Chang I, Novas M, Rana J, Marantz JL. Characterizing absolute lymphocyte count profiles in dimethyl fumarate-treated patients with MS: Patient management considerations. Neurology. Clinical Practice. 6: 220-229. PMID 27347439 DOI: 10.1212/CPJ.0000000000000238  1
2016 Otero-Romero S, Sastre-Garriga J, Comi G, Hartung HP, Soelberg Sørensen P, Thompson AJ, Vermersch P, Gold R, Montalban X. Pharmacological management of spasticity in multiple sclerosis: Systematic review and consensus paper. Multiple Sclerosis (Houndmills, Basingstoke, England). PMID 27207462 DOI: 10.1177/1352458516643600  1
2016 Gold R, Arnold DL, Bar-Or A, Hutchinson M, Kappos L, Havrdova E, MacManus DG, Yousry TA, Pozzilli C, Selmaj K, Sweetser MT, Zhang R, Yang M, Potts J, Novas M, et al. Long-term effects of delayed-release dimethyl fumarate in multiple sclerosis: Interim analysis of ENDORSE, a randomized extension study. Multiple Sclerosis (Houndmills, Basingstoke, England). PMID 27207449 DOI: 10.1177/1352458516649037  1
2016 Massa MG, Gisevius B, Hirschberg S, Hinz L, Schmidt M, Gold R, Prochnow N, Haghikia A. Multiple Sclerosis Patient-Specific Primary Neurons Differentiated from Urinary Renal Epithelial Cells via Induced Pluripotent Stem Cells. Plos One. 11: e0155274. PMID 27158987 DOI: 10.1371/Journal.Pone.0155274  1
2016 Stangel M, Gold R, Pittrow D, Baumann U, Borte M, Fasshauer M, Hensel M, Huscher D, Reiser M, Sommer C. Treatment of patients with multifocal motor neuropathy with immunoglobulins in clinical practice: the SIGNS registry. Therapeutic Advances in Neurological Disorders. 9: 165-79. PMID 27134672 DOI: 10.1177/1756285616629869  1
2016 Schneider R, Bellenberg B, Kleiter I, Gold R, Köster O, Weiler F, Hahn H, Lukas C. Cervical cord and ventricle affection in neuromyelitis optica. Acta Neurologica Scandinavica. PMID 27098675 DOI: 10.1111/ane.12601  1
2016 Haghikia A, Jörg S, Duscha A, Berg J, Manzel A, Waschbisch A, Hammer A, Lee DH, May C, Wilck N, Balogh A, Ostermann AI, Schebb NH, Akkad DA, Grohme DA, ... ... Gold R, et al. Dietary Fatty Acids Directly Impact Central Nervous System Autoimmunity via the Small Intestine. Immunity. 44: 951-953. PMID 27096322 DOI: 10.1016/j.immuni.2016.04.006  1
2016 Kleiter I, Ayzenberg I, Araki M, Yamamura T, Gold R. Tocilizumab, MS, and NMOSD. Multiple Sclerosis (Houndmills, Basingstoke, England). PMID 27068554 DOI: 10.1177/1352458516643395  1
2016 Kerasnoudis A, Pitarokoili K, Haghikia A, Gold R, Yoon MS. Nerve ultrasound protocol in differentiating chronic immune-mediated neuropathies. Muscle & Nerve. PMID 27061901 DOI: 10.1002/Mus.25138  1
2016 Faissner S, Nikolayczik J, Chan A, Hellwig K, Gold R, Yoon MS, Haghikia A. Plasmapheresis and immunoadsorption in patients with steroid refractory multiple sclerosis relapses. Journal of Neurology. PMID 27039388 DOI: 10.1007/S00415-016-8105-4  1
2016 Jörg S, Kissel J, Manzel A, Kleinewietfeld M, Haghikia A, Gold R, Müller DN, Linker RA. High salt drives Th17 responses in experimental autoimmune encephalomyelitis without impacting myeloid dendritic cells. Experimental Neurology. 279: 212-222. PMID 26976739 DOI: 10.1016/J.Expneurol.2016.03.010  1
2016 Recke A, Oei A, Hübner F, Fechner K, Graf J, Hagenah J, May C, Woitalla D, Salmen A, Zillikens D, Gold R, Schlumberger W, Schmidt E. Parkinson's disease and multiple sclerosis are not associated with autoantibodies against structural proteins of the dermal-epidermal junction. The British Journal of Dermatology. PMID 26972435 DOI: 10.1111/Bjd.14538  1
2016 Haghikia A, Gold R. Positive Effect on Multiple Sclerosis With Treatment of Metabolic Syndrome. Jama Neurology. PMID 26954938 DOI: 10.1001/Jamaneurol.2015.5050  1
2016 Grüter T, Strassburger-Krogias K, Hoepner R, Schroeder C, Haller S, Gold R, Krogias C. Basal ganglia alterations appearing in transcranial sonography prior to MRI in a patient with Creutzfeld-Jacob Disease. Journal of the Neurological Sciences. 362: 339-40. PMID 26944174 DOI: 10.1016/J.Jns.2016.02.010  1
2016 Thöne J, Kleiter I, Stahl A, Ellrichmann G, Gold R, Hellwig K. Relevance of endoglin, IL-1α, IL-1β and anti-ovarian antibodies in females with multiple sclerosis. Journal of the Neurological Sciences. 362: 240-3. PMID 26944156 DOI: 10.1016/J.Jns.2016.01.057  1
2016 Krogias C, Ayzenberg I, Schroeder C, Grüter T, Gold R, Yoon MS. Transorbital sonography in CIDP patients: No evidence for optic nerve hypertrophy. Journal of the Neurological Sciences. 362: 206-8. PMID 26944149 DOI: 10.1016/J.Jns.2016.01.049  1
2016 Gold R, Giovannoni G, Phillips JT, Fox RJ, Zhang A, Marantz JL. Sustained Effect of Delayed-Release Dimethyl Fumarate in Newly Diagnosed Patients with Relapsing-Remitting Multiple Sclerosis: 6-Year Interim Results From an Extension of the DEFINE and CONFIRM Studies. Neurology and Therapy. PMID 26932146 DOI: 10.1007/S40120-016-0042-8  1
2016 Klotz L, Berthele A, Brück W, Chan A, Flachenecker P, Gold R, Haghikia A, Hellwig K, Hemmer B, Hohlfeld R, Korn T, Kümpfel T, Lang M, Limmroth V, Linker RA, et al. [Monitoring of blood parameters under course-modified MS therapy : Substance-specific relevance and current recommendations for action]. Der Nervenarzt. PMID 26927677 DOI: 10.1007/S00115-016-0077-1  1
2016 Thiel S, Langer-Gould A, Rockhoff M, Haghikia A, Queisser-Wahrendorf A, Gold R, Hellwig K. Interferon-beta exposure during first trimester is safe in women with multiple sclerosis-A prospective cohort study from the German Multiple Sclerosis and Pregnancy Registry. Multiple Sclerosis (Houndmills, Basingstoke, England). PMID 26920382 DOI: 10.1177/1352458516634872  1
2016 Melzer N, Ruck T, Fuhr P, Gold R, Hohlfeld R, Marx A, Melms A, Tackenberg B, Schalke B, Schneider-Gold C, Zimprich F, Meuth SG, Wiendl H. Clinical features, pathogenesis, and treatment of myasthenia gravis: a supplement to the Guidelines of the German Neurological Society. Journal of Neurology. PMID 26886206 DOI: 10.1007/S00415-016-8045-Z  1
2016 Radue EW, Sprenger T, Vollmer T, Giovannoni G, Gold R, Havrdova E, Selmaj K, Stefoski D, You X, Elkins J. Daclizumab high-yield process reduced the evolution of new gadolinium-enhancing lesions to T1 black holes in patients with relapsing-remitting multiple sclerosis. European Journal of Neurology. 23: 412-5. PMID 26806217 DOI: 10.1111/ene.12922  1
2016 Herbstritt S, Langer-Gould A, Rockhoff M, Haghikia A, Queisser-Wahrendorf A, Gold R, Hellwig K. Glatiramer acetate during early pregnancy: A prospective cohort study. Multiple Sclerosis (Houndmills, Basingstoke, England). PMID 26754804 DOI: 10.1177/1352458515623366  1
2016 Vermersch P, Gold R, Holloway C, Rovira A, Giovannoni G, Toumi M. Multi-stakeholder Colloquium – Opportunities and Challenges in Multiple Sclerosis Management European Neurological Review. 11: 41. DOI: 10.17925/Enr.2016.11.01.41  1
2016 Gasperi C, Krysta A, Antony G, Bayas A, Gold R, Heesen C, Kuempfel T, Linker RA, Paul F, Stangel M, Tackenberg B, Bergh FT, Tumani H, Warnke C, Weber F, et al. Genetic variants associated with intrathecal synthesis of IgG, IgM and IgA in multiple sclerosis Multiple Sclerosis Journal. 22: 486-487. DOI: 10.1177/1352458516663086  1
2016 Radue E, Giovannoni G, Gold R, Selmaj K, Havrdova E, Stefoski D, Sprenger T, Montalban X, Riester K, Ozen G. Daclizumab Hyp In Multiple Sclerosis: 3-Year Results From Selected Journal of Neurology, Neurosurgery, and Psychiatry. 87. DOI: 10.1136/Jnnp-2016-315106.141  1
2016 Fatoba O, Kloster E, Saft C, Gold R, Arning L, Ellrichmann G. L22 Intranasal application of NPY and NPY13–36 ameliorate disease pathology in R6/2 mouse model of huntington’s disease Journal of Neurology, Neurosurgery, and Psychiatry. 87. DOI: 10.1136/Jnnp-2016-314597.277  1
2016 Ellrichmann G, Blusch A, Fatoba O, Brunner J, Pitarokoili K, Hayardeny L, Saft C, Gold R. L7 Laquinimod in the R6/2 mouse model of huntington’s disease Journal of Neurology, Neurosurgery, and Psychiatry. 87. DOI: 10.1136/Jnnp-2016-314597.262  1
2016 Herbstritt S, Gold R, Hellwig K. Glatiramer Acetate And Pregnancy In Women With Multiple Sclerosis – Results From The German Multiple Sclerosis And Pregnancy Registry Archives of Disease in Childhood. 101. DOI: 10.1136/Archdischild-2015-310148.40  1
2016 Fatoba O, Ellrichmann G, Saft C, Kloster E, Gold R, Arning L. Activation of neuropeptide-Y2 receptor mediates neuroprotection in cellular model of Huntington's disease Neuropeptides. 55: 5. DOI: 10.1016/J.Npep.2015.11.012  1
2016 Ellrichmann G, Behrendt V, Grunwald C, Schlottmann R, Lukas C, Gold R. Cidofovir for treatment of progressive multifocal leukoencephalopathy in a newly diagnosed sarcoidosis patient - A valid therapeutic option? Journal of the Neurological Sciences. 362: 341-343. DOI: 10.1016/j.jns.2016.02.011  1
2016 Kerasnoudis A, Pitarokoili K, Gold R, Yoon M-. FV 7. Nerve ultrasound protocol in differentiating chronic neuritis Clinical Neurophysiology. 127. DOI: 10.1016/J.Clinph.2016.05.024  1
2015 Schrewe L, Lill CM, Liu T, Salmen A, Gerdes LA, Guillot-Noel L, Akkad DA, Blaschke P, Graetz C, Hoffjan S, Kroner A, Demir S, Böhme A, Rieckmann P, ElAli A, ... ... Gold R, et al. Investigation of sex-specific effects of apolipoprotein E on severity of EAE and MS. Journal of Neuroinflammation. 12: 234. PMID 26669675 DOI: 10.1186/S12974-015-0429-Y  1
2015 Gold R, Phillips JT, Havrdova E, Bar-Or A, Kappos L, Kim N, Thullen T, Valencia P, Oliva L, Novas M, Li J, Sweetser MT, Kurukulasuriya N, Viglietta V, Fox RJ. Delayed-Release Dimethyl Fumarate and Pregnancy: Preclinical Studies and Pregnancy Outcomes from Clinical Trials and Postmarketing Experience. Neurology and Therapy. 4: 93-104. PMID 26662361 DOI: 10.1007/S40120-015-0033-1  1
2015 Pitarokoili K, Ambrosius B, Meyer D, Schrewe L, Gold R. Dimethyl Fumarate Ameliorates Lewis Rat Experimental Autoimmune Neuritis and Mediates Axonal Protection. Plos One. 10: e0143416. PMID 26618510 DOI: 10.1371/Journal.Pone.0143416  1
2015 Kleiter I, Gold R. Present and Future Therapies in Neuromyelitis Optica Spectrum Disorders. Neurotherapeutics : the Journal of the American Society For Experimental Neurotherapeutics. PMID 26597098 DOI: 10.1007/S13311-015-0400-8  1
2015 Pitarokoili K, Kerasnoudis A, Behrendt V, Labedi A, Ayzenberg I, Gold R, Yoon MS. Facing the diagnostic challenge: Nerve ultrasound in diabetic patients with neuropathic symptoms. Muscle & Nerve. PMID 26575030 DOI: 10.1002/Mus.24981  1
2015 Ayzenberg I, Nastos I, Strassburger-Krogias K, Obermann M, Gold R, Krogias C. Hypoechogenicity of brainstem raphe nuclei is associated with increased attack frequency in episodic migraine. Cephalalgia : An International Journal of Headache. PMID 26566936 DOI: 10.1177/0333102415617415  1
2015 Faissner S, Hoepner R, Lukas C, Chan A, Gold R, Ellrichmann G. Tumefactive multiple sclerosis lesions in two patients after cessation of fingolimod treatment. Therapeutic Advances in Neurological Disorders. 8: 233-8. PMID 26557898 DOI: 10.1177/1756285615594575  1
2015 Nanni IM, Pirondi A, Mancini D, Stammler G, Gold R, Ferri I, Brunelli A, Collina M. Differences in the efficacy of Carboxylic Acid Amides (CAA) fungicides against less sensitive strains of Plasmopara viticola. Pest Management Science. PMID 26537744 DOI: 10.1002/ps.4182  0.01
2015 Giovannoni G, Gold R, Fox RJ, Kappos L, Kita M, Yang M, Sarda SP, Zhang R, Viglietta V, Havrdova E. Relapses Requiring Intravenous Steroid Use and Multiple-Sclerosis-Related Hospitalizations: Integrated Analysis of the Delayed-Release Dimethyl Fumarate Phase III Studies. Clinical Therapeutics. PMID 26526385 DOI: 10.1016/J.Clinthera.2015.09.011  1
2015 Dankowski T, Buck D, Andlauer TF, Antony G, Bayas A, Bechmann L, Berthele A, Bettecken T, Chan A, Franke A, Gold R, Graetz C, Haas J, Hecker M, Herms S, et al. Successful Replication of GWAS Hits for Multiple Sclerosis in 10,000 Germans Using the Exome Array. Genetic Epidemiology. PMID 26497834 DOI: 10.1002/Gepi.21933  1
2015 Marino M, Bailey SR, Gold R, Hoopes MJ, O'Malley JP, Huguet N, Heintzman J, Gallia C, McConnell KJ, DeVoe JE. Receipt of Preventive Services After Oregon's Randomized Medicaid Experiment. American Journal of Preventive Medicine. PMID 26497264 DOI: 10.1016/J.Amepre.2015.07.032  1
2015 Haghikia A, Jörg S, Duscha A, Berg J, Manzel A, Waschbisch A, Hammer A, Lee DH, May C, Wilck N, Balogh A, Ostermann AI, Schebb NH, Akkad DA, Grohme DA, ... ... Gold R, et al. Dietary Fatty Acids Directly Impact Central Nervous System Autoimmunity via the Small Intestine. Immunity. 43: 817-29. PMID 26488817 DOI: 10.1016/J.Immuni.2015.09.007  1
2015 Kurre W, Berlis A, Diener HC, Fiehler J, Gold R, Groden C, Hamann GF, Röther J, Eckert B. Clinical Neuroradiology. PMID 26480874 DOI: 10.1007/S00062-015-0475-Y  1
2015 Gold R, Hollombe C, Bunce A, Nelson C, Davis JV, Cowburn S, Perrin N, DeVoe J, Mossman N, Boles B, Horberg M, Dearing JW, Jaworski V, Cohen D, Smith D. Study protocol for "Study of Practices Enabling Implementation and Adaptation in the Safety Net (SPREAD-NET)": a pragmatic trial comparing implementation strategies. Implementation Science : Is. 10: 144. PMID 26474759 DOI: 10.1186/S13012-015-0333-Y  1
2015 Phillips JT, Selmaj K, Gold R, Fox RJ, Havrdova E, Giovannoni G, Abourjaily H, Pace A, Novas M, Hotermans C, Viglietta V, Meltzer L. Clinical Significance of Gastrointestinal and Flushing Events in Patients with Multiple Sclerosis Treated with Delayed-Release Dimethyl Fumarate. International Journal of Ms Care. 17: 236-43. PMID 26472945 DOI: 10.7224/1537-2073.2014-069  1
2015 Keefer TC, Puckett RT, Brown KS, Gold RE. Field Trials With 0.5% Novaluron Insecticide Applied as a Bait to Control Subterranean Termites (Reticulitermes sp. and Coptotermes formosanus [Isoptera: Rhinotermitidae]) on Structures. Journal of Economic Entomology. 108: 2407-13. PMID 26453729 DOI: 10.1093/jee/tov200  1
2015 Schwab N, Schneider-Hohendorf T, Pignolet B, Spadaro M, Görlich D, Meinl I, Windhagen S, Tackenberg B, Breuer J, Cantó E, Kümpfel T, Hohlfeld R, Siffrin V, Luessi F, Posevitz-Fejfár A, ... ... Gold R, et al. PML risk stratification using anti-JCV antibody index and L-selectin. Multiple Sclerosis (Houndmills, Basingstoke, England). PMID 26432858 DOI: 10.1177/1352458515607651  1
2015 Belharazem D, Schalke B, Gold R, Nix W, Vitacolonna M, Hohenberger P, Roessner E, Schulze TJ, Saruhan-Direskeneli G, Yilmaz V, Ott G, Ströbel P, Marx A. cFLIP overexpression in T cells in thymoma-associated myasthenia gravis. Annals of Clinical and Translational Neurology. 2: 894-905. PMID 26401511 DOI: 10.1002/Acn3.210  1
2015 Yamashiro H, Cutcliffe N, Dobson S, Fisman D, Gold R. The role of pediatricians as key stakeholders in influencing immunization policy decisions for the introduction of meningitis B vaccine in Canada: The Ontario perspective. The Canadian Journal of Infectious Diseases & Medical Microbiology = Journal Canadien Des Maladies Infectieuses Et De La Microbiologie MéDicale / Ammi Canada. 26: 183-90. PMID 26361485  1
2015 Gold R, Burdick T, Angier H, Wallace L, Nelson C, Likumahuwa-Ackman S, Sumic A, DeVoe JE. Improve Synergy Between Health Information Exchange and Electronic Health Records to Increase Rates of Continuously Insured Patients. Egems (Washington, Dc). 3: 1158. PMID 26355818 DOI: 10.13063/2327-9214.1158  1
2015 Bauer J, Gold R, Adams O, Lassmann H. Progressive multifocal leukoencephalopathy and immune reconstitution inflammatory syndrome (IRIS). Acta Neuropathologica. PMID 26323992 DOI: 10.1007/S00401-015-1471-7  1
2015 Hellwig K, Rockhoff M, Herbstritt S, Borisow N, Haghikia A, Elias-Hamp B, Menck S, Gold R, Langer-Gould A. Exclusive Breastfeeding and the Effect on Postpartum Multiple Sclerosis Relapses. Jama Neurology. 72: 1132-8. PMID 26322399 DOI: 10.1001/Jamaneurol.2015.1806  1
2015 Reed JJ, Puckett RT, Gold RE. Induced Effects on Red Imported Fire Ant (Hymenoptera: Formicidae) Forager Size Ratios by Pseudacteon spp. (Diptera: Phoridae): Implications on Bait Size Selection. Environmental Entomology. 44: 1407-16. PMID 26314020 DOI: 10.1093/ee/nvv118  1
2015 DeVoe JE, Tillotson CJ, Marino M, O'Malley J, Angier H, Wallace LS, Gold R. Trends in Type of Health Insurance Coverage for US Children and Their Parents, 1998-2011. Academic Pediatrics. PMID 26297668 DOI: 10.1016/j.acap.2015.06.009  1
2015 McCarville MB, Chen JY, Coleman JL, Li Y, Li X, Adderson EE, Neel MD, Gold RE, Kaufman RA. Distinguishing Osteomyelitis From Ewing Sarcoma on Radiography and MRI. Ajr. American Journal of Roentgenology. 205: 640-50; quiz 651. PMID 26295653 DOI: 10.2214/AJR.15.14341  1
2015 Angier H, Marino M, Sumic A, O'Malley J, Likumahuwa-Ackman S, Hoopes M, Nelson C, Gold R, Cohen D, Dickerson K, DeVoe JE. Innovative Methods for Parents And Clinics to Create Tools for Kids' Care (IMPACCT Kids' Care) Study Protocol. Contemporary Clinical Trials. PMID 26291916 DOI: 10.1016/j.cct.2015.08.010  1
2015 Kolber P, Luessi F, Meuth SG, Klotz L, Korn T, Trebst C, Tackenberg B, Kieseier B, Kümpfel T, Fleischer V, Tumani H, Wildemann B, Lang M, Flachenecker P, Meier U, ... ... Gold R, et al. [Current aspects of therapy conversion for multiple sclerosis]. Der Nervenarzt. 86: 1236-47. PMID 26269289 DOI: 10.1007/S00115-015-4368-8  1
2015 Haghikia A, Gold R. [In Process Citation]. Der Nervenarzt. 86: 757. PMID 26261862  1
2015 Kerasnoudis A, Pitarokoili K, Gold R, Yoon MS. Nerve Ultrasound and Electrophysiology for Therapy Monitoring in Chronic Inflammatory Demyelinating Polyneuropathy. Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging. PMID 26242571 DOI: 10.1111/Jon.12279  1
2015 Pitarokoili K, Schlamann M, Kerasnoudis A, Gold R, Yoon MS. Comparison of clinical, electrophysiological, sonographic and MRI features in CIDP. Journal of the Neurological Sciences. 357: 198-203. PMID 26227829 DOI: 10.1016/J.Jns.2015.07.030  1
2015 Hartung HP, Gold R. [People in view, brain in focus]. Der Nervenarzt. 86: 923-4. PMID 26208545 DOI: 10.1007/s00115-014-4247-8  1
2015 Demir S, Heckers S, Pedreiturria X, Hess D, Trampe AK, Chan A, Gold R. Low dose fumaric acid esters are effective in a mouse model of spontaneous chronic encephalomyelitis. Journal of Neuroimmunology. 285: 16-21. PMID 26198914 DOI: 10.1016/J.Jneuroim.2015.05.010  1
2015 DeVoe JE, Marino M, Gold R, Hoopes MJ, Cowburn S, O'Malley JP, Heintzman J, Gallia C, McConnell KJ, Nelson CA, Huguet N, Bailey SR. Community Health Center Use After Oregon's Randomized Medicaid Experiment. Annals of Family Medicine. 13: 312-20. PMID 26195674 DOI: 10.1370/Afm.1812  1
2015 Hoepner R, Behrendt V, Meves S, Gold R, Krogias C. Dagibatran Etexilate: Is There Any Need for Coagulation Monitoring After Initiation? The Neurologist. 20: 1-3. PMID 26185953 DOI: 10.1097/Nrl.0000000000000034  1
2015 Bazemore AW, Cottrell EK, Gold R, Hughes LS, Phillips RL, Angier H, Burdick TE, Carrozza MA, DeVoe JE. "Community Vital Signs": Incorporating geocoded social determinants into electronic records to promote patient and population health. Journal of the American Medical Informatics Association : Jamia. PMID 26174867 DOI: 10.1093/jamia/ocv088  1
2015 Yoon MS, Gold R, Kerasnoudis A. Subcutaneous immunoglobulin in treating inflammatory neuromuscular disorders. Therapeutic Advances in Neurological Disorders. 8: 153-9. PMID 26136842 DOI: 10.1177/1756285615584739  1
2015 Schneider-Gold C, Bellenberg B, Prehn C, Krogias C, Schneider R, Klein J, Gold R, Lukas C. Cortical and Subcortical Grey and White Matter Atrophy in Myotonic Dystrophies Type 1 and 2 Is Associated with Cognitive Impairment, Depression and Daytime Sleepiness. Plos One. 10: e0130352. PMID 26114298 DOI: 10.1371/Journal.Pone.0130352  1
2015 Schneider-Gold C, Krogias C, Neusch C, Hasselblatt M, Gold R. SonoGraphic monitoring of severe focal B-cell myositis of the anterior calf muscle responsive to rituximab. Muscle & Nerve. 52: 911-3. PMID 26112150 DOI: 10.1002/Mus.24751  1
2015 Bolz J, Meves SH, Kara K, Reinacher-Schick A, Gold R, Krogias C. Multiple cerebral infarctions in a young patient with heroin-induced hypereosinophilic syndrome. Journal of the Neurological Sciences. 356: 193-5. PMID 26104570 DOI: 10.1016/J.Jns.2015.06.031  1
2015 Gold R, Nelson C, Cowburn S, Bunce A, Hollombe C, Davis J, Muench J, Hill C, Mital M, Puro J, Perrin N, Nichols G, Turner A, Mercer M, Jaworski V, et al. Feasibility and impact of implementing a private care system's diabetes quality improvement intervention in the safety net: a cluster-randomized trial. Implementation Science : Is. 10: 83. PMID 26059264 DOI: 10.1186/s13012-015-0259-4  1
2015 Haghikia A, Kayacelebi AA, Beckmann B, Hanff E, Gold R, Haghikia A, Tsikas D. Serum and cerebrospinal fluid concentrations of homoarginine, arginine, asymmetric and symmetric dimethylarginine, nitrite and nitrate in patients with multiple sclerosis and neuromyelitis optica. Amino Acids. 47: 1837-45. PMID 26055922 DOI: 10.1007/S00726-015-2015-0  1
2015 Stasiolek M, Linker RA, Hayardeny L, Bar Ilan O, Gold R. Immune parameters of patients treated with laquinimod, a novel oral therapy for the treatment of multiple sclerosis: results from a double-blind placebo-controlled study. Immunity, Inflammation and Disease. 3: 45-55. PMID 26029365 DOI: 10.1002/Iid3.42  1
2015 Akkad DA, Olischewsky A, Reiner F, Hellwig K, Esser S, Epplen JT, Curk T, Gold R, Haghikia A. Combinations of susceptibility genes are associated with higher risk for multiple sclerosis and imply disease course specificity. Plos One. 10: e0127632. PMID 26011527 DOI: 10.1371/Journal.Pone.0127632  1
2015 Bellenberg B, Schneider R, Weiler F, Suchan B, Haghikia A, Hoffjan S, Gold R, Köster O, Lukas C. Cervical cord area is associated with infratentorial grey and white matter volume predominantly in relapsing-remitting multiple sclerosis: A study using semi-automated cord volumetry and voxel-based morphometry. Multiple Sclerosis and Related Disorders. 4: 264-72. PMID 26008944 DOI: 10.1016/J.Msard.2015.04.003  1
2015 Ringelstein M, Ayzenberg I, Harmel J, Lauenstein AS, Lensch E, Stögbauer F, Hellwig K, Ellrichmann G, Stettner M, Chan A, Hartung HP, Kieseier B, Gold R, Aktas O, Kleiter I. Long-term Therapy With Interleukin 6 Receptor Blockade in Highly Active Neuromyelitis Optica Spectrum Disorder. Jama Neurology. 72: 756-63. PMID 25985228 DOI: 10.1001/Jamaneurol.2015.0533  1
2015 Walsh JT, Hendrix S, Boato F, Smirnov I, Zheng J, Lukens JR, Gadani S, Hechler D, Gölz G, Rosenberger K, Kammertöns T, Vogt J, Vogelaar C, Siffrin V, Radjavi A, ... ... Gold R, et al. MHCII-independent CD4+ T cells protect injured CNS neurons via IL-4. The Journal of Clinical Investigation. 125: 2547. PMID 25938785 DOI: 10.1172/JCI82458  1
2015 Chae DH, Clouston S, Hatzenbuehler ML, Kramer MR, Cooper HL, Wilson SM, Stephens-Davidowitz SI, Gold RS, Link BG. Association between an Internet-Based Measure of Area Racism and Black Mortality. Plos One. 10: e0122963. PMID 25909964 DOI: 10.1371/Journal.Pone.0122963  1
2015 Krogias C, Gold R, Chan A, Triantafyllou N, Voumvourakis K, Tsivgoulis G. Brain Hyperechogenicities are not Associated with Venous Insufficiency in Multiple Sclerosis: A Pilot Neurosonology Study. Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging. PMID 25891137 DOI: 10.1111/Jon.12248  1
2015 Heintzman J, Marino M, Hoopes M, Bailey SR, Gold R, O'Malley J, Angier H, Nelson C, Cottrell E, Devoe J. Supporting health insurance expansion: do electronic health records have valid insurance verification and enrollment data? Journal of the American Medical Informatics Association : Jamia. 22: 909-13. PMID 25888586 DOI: 10.1093/Jamia/Ocv033  1
2015 DeVoe JE, Crawford C, Angier H, O'Malley J, Gallia C, Marino M, Gold R. The Association Between Medicaid Coverage for Children and Parents Persists: 2002-2010. Maternal and Child Health Journal. 19: 1766-74. PMID 25874876 DOI: 10.1007/s10995-015-1690-5  1
2015 Metz I, Traffehn S, Straßburger-Krogias K, Keyvani K, Bergmann M, Nolte K, Weber MS, Bartsch T, Gold R, Brück W. Glial cells express nuclear nrf2 after fumarate treatment for multiple sclerosis and psoriasis. Neurology® Neuroimmunology & Neuroinflammation. 2: e99. PMID 25866832 DOI: 10.1212/Nxi.0000000000000099  1
2015 Kohlmann R, Salmen A, Chan A, Knabbe C, Diekmann J, Brockmeyer N, Skaletz-Rorowski A, Michalik C, Gold R, Überla K. Serological evidence of increased susceptibility to varicella-zoster virus reactivation or reinfection in natalizumab-treated patients with multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). PMID 25828755 DOI: 10.1177/1352458515576984  1
2015 Hoepner R, Faissner S, Klasing A, Schneider R, Metz I, Bellenberg B, Lukas C, Altmeyer P, Gold R, Chan A. Progressive multifocal leukoencephalopathy during fumarate monotherapy of psoriasis. Neurology® Neuroimmunology & Neuroinflammation. 2: e85. PMID 25798449 DOI: 10.1212/Nxi.0000000000000085  1
2015 Novkovic T, Shchyglo O, Gold R, Manahan-Vaughan D. Hippocampal function is compromised in an animal model of multiple sclerosis. Neuroscience. PMID 25795599 DOI: 10.1016/J.Neuroscience.2015.03.008  0.01
2015 Haghikia A, Gold R. [Is the use of placebo as control group in MS drug trials still appropriate?]. Der Nervenarzt. 86: 481-2. PMID 25787726 DOI: 10.1007/S00115-015-4283-Z  1
2015 Viglietta V, Miller D, Bar-Or A, Phillips JT, Arnold DL, Selmaj K, Kita M, Hutchinson M, Yang M, Zhang R, Dawson KT, Sheikh SI, Fox RJ, Gold R. Efficacy of delayed-release dimethyl fumarate in relapsing-remitting multiple sclerosis: integrated analysis of the phase 3 trials. Annals of Clinical and Translational Neurology. 2: 103-18. PMID 25750916 DOI: 10.1002/Acn3.148  1
2015 Tsivgoulis G, Faissner S, Voumvourakis K, Katsanos AH, Triantafyllou N, Grigoriadis N, Gold R, Krogias C. "Liberation treatment" for chronic cerebrospinal venous insufficiency in multiple sclerosis: the truth will set you free. Brain and Behavior. 5: 3-12. PMID 25722945 DOI: 10.1002/Brb3.297  1
2015 Hoepner R, Klotz P, Faissner S, Schneider R, Kinner M, Prehn C, Gold R, Chan A. Neuropsychological impairment in natalizumab-associated progressive multifocal leukoencephalopathy: implications for early diagnosis. Journal of Neurology, Neurosurgery, and Psychiatry. PMID 25628377 DOI: 10.1136/Jnnp-2014-310287  1
2015 Linker RA, Lee DH, Flach AC, Litke T, van den Brandt J, Reichardt HM, Lingner T, Bommhardt U, Sendtner M, Gold R, Flügel A, Lühder F. Thymocyte-derived BDNF influences T-cell maturation at the DN3/DN4 transition stage. European Journal of Immunology. 45: 1326-38. PMID 25627579 DOI: 10.1002/Eji.201444985  1
2015 Akkad DA, Bellenberg B, Esser S, Weiler F, Epplen JT, Gold R, Lukas C, Haghikia A. Multiple sclerosis risk loci correlate with cervical cord atrophy and may explain the course of disability. Neurogenetics. 16: 161-8. PMID 25620546 DOI: 10.1007/S10048-015-0438-0  1
2015 Pitarokoili K, Gold R, Yoon MS. Nerve ultrasound in a case of multifocal motor neuropathy without conduction block. Muscle & Nerve. 52: 294-9. PMID 25620065 DOI: 10.1002/Mus.24583  1
2015 Walsh JT, Hendrix S, Boato F, Smirnov I, Zheng J, Lukens JR, Gadani S, Hechler D, Gölz G, Rosenberger K, Kammertöns T, Vogt J, Vogelaar C, Siffrin V, Radjavi A, ... ... Gold R, et al. MHCII-independent CD4+ T cells protect injured CNS neurons via IL-4. The Journal of Clinical Investigation. 125: 699-714. PMID 25607842 DOI: 10.1172/Jci76210  1
2015 Droby A, Lukas C, Schänzer A, Spiwoks-Becker I, Giorgio A, Gold R, De Stefano N, Kugel H, Deppe M, Wiendl H, Meuth SG, Acker T, Zipp F, Deichmann R. A human post-mortem brain model for the standardization of multi-centre MRI studies. Neuroimage. 110: 11-21. PMID 25595502 DOI: 10.1016/J.Neuroimage.2015.01.028  1
2015 Angier H, Hoopes M, Gold R, Bailey SR, Cottrell EK, Heintzman J, Marino M, DeVoe JE. An early look at rates of uninsured safety net clinic visits after the Affordable Care Act. Annals of Family Medicine. 13: 10-6. PMID 25583886 DOI: 10.1370/Afm.1741  1
2015 DeVoe JE, Marino M, Angier H, O'Malley JP, Crawford C, Nelson C, Tillotson CJ, Bailey SR, Gallia C, Gold R. Effect of expanding medicaid for parents on children's health insurance coverage: lessons from the Oregon experiment. Jama Pediatrics. 169: e143145. PMID 25561041 DOI: 10.1001/Jamapediatrics.2014.3145  1
2015 Kappos L, Giovannoni G, Gold R, Phillips JT, Arnold DL, Hotermans C, Zhang A, Viglietta V, Fox RJ. Time course of clinical and neuroradiological effects of delayed-release dimethyl fumarate in multiple sclerosis. European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies. 22: 664-71. PMID 25557371 DOI: 10.1111/Ene.12624  1
2015 Kerasnoudis A, Pitarokoili K, Gold R, Yoon MS. Bochum ultrasound score allows distinction of chronic inflammatory from multifocal acquired demyelinating polyneuropathies. Journal of the Neurological Sciences. 348: 211-5. PMID 25534358 DOI: 10.1016/J.Jns.2014.12.010  1
2015 Skripuletz T, Manzel A, Gropengießer K, Schäfer N, Gudi V, Singh V, Salinas Tejedor L, Jörg S, Hammer A, Voss E, Vulinovic F, Degen D, Wolf R, Lee DH, Pul R, ... ... Gold R, et al. Pivotal role of choline metabolites in remyelination. Brain : a Journal of Neurology. 138: 398-413. PMID 25524711 DOI: 10.1093/Brain/Awu358  1
2015 Interiano RB, Loh AH, Hinkle N, Wahid FN, Malkan AD, Bahrami A, Jenkins JJ, Mao S, Wu J, Proctor K, Santana VM, Pappo AS, Gold RE, Davidoff AM. Safety and diagnostic accuracy of tumor biopsies in children with cancer. Cancer. 121: 1098-107. PMID 25524504 DOI: 10.1002/cncr.29167  1
2015 Gold RM, Schneider S, Forstner MR, Hoppes SM, Porter BF. Pathology in practice. Journal of the American Veterinary Medical Association. 246: 63-5. PMID 25517327 DOI: 10.2460/javma.246.1.63  1
2015 Grey Née Cotte S, Salmen Née Stroet A, von Ahsen N, Starck M, Winkelmann A, Zettl UK, Comabella M, Montalban X, Zipp F, Fleischer V, Kruse N, Gold R, Chan A. Lack of efficacy of mitoxantrone in primary progressive Multiple Sclerosis irrespective of pharmacogenetic factors: a multi-center, retrospective analysis. Journal of Neuroimmunology. 278: 277-9. PMID 25468777 DOI: 10.1016/J.Jneuroim.2014.11.017  1
2015 Bailey SR, O'Malley JP, Gold R, Heintzman J, Marino M, DeVoe JE. Receipt of diabetes preventive services differs by insurance status at visit. American Journal of Preventive Medicine. 48: 229-33. PMID 25442228 DOI: 10.1016/J.Amepre.2014.08.035  1
2015 Warnke C, Stettner M, Lehmensiek V, Dehmel T, Mausberg AK, von Geldern G, Gold R, Kümpfel T, Hohlfeld R, Mäurer M, Stangel M, Straeten V, Limmroth V, Weber T, Kleinschnitz C, et al. Natalizumab exerts a suppressive effect on surrogates of B cell function in blood and CSF. Multiple Sclerosis (Houndmills, Basingstoke, England). 21: 1036-44. PMID 25392339 DOI: 10.1177/1352458514556296  1
2015 Krogias C, Bellenberg B, Prehn C, Schneider R, Meves SH, Gold R, Lukas C, Schneider-Gold C. Evaluation of CNS involvement in myotonic dystrophy type 1 and type 2 by transcranial sonography. Journal of Neurology. 262: 365-74. PMID 25385052 DOI: 10.1007/S00415-014-7566-6  1
2015 Bhojwani D, McCarville MB, Choi JK, Sawyer J, Metzger ML, Inaba H, Davidoff AM, Gold R, Shulkin BL, Sandlund JT. The role of FDG-PET/CT in the evaluation of residual disease in paediatric non-Hodgkin lymphoma. British Journal of Haematology. 168: 845-53. PMID 25382494 DOI: 10.1111/bjh.13219  1
2015 Kaufman M, Cree BA, De Sèze J, Fox RJ, Gold R, Hartung HP, Jeffery D, Kappos L, Montalbán X, Weinstock-Guttman B, Ticho B, Duda P, Pace A, Campagnolo D. Radiologic MS disease activity during natalizumab treatment interruption: findings from RESTORE. Journal of Neurology. 262: 326-36. PMID 25381458 DOI: 10.1007/S00415-014-7558-6  1
2015 Kerasnoudis A, Pitarokoili K, Behrendt V, Gold R, Yoon MS. Bochum ultrasound score versus clinical and electrophysiological parameters in distinguishing acute-onset chronic from acute inflammatory demyelinating polyneuropathy. Muscle & Nerve. 51: 846-52. PMID 25297575 DOI: 10.1002/Mus.24484  1
2015 Comi G, Gold R, Dahlke F, Sinha A, von Rosenstiel P, Tomic D, Kappos L. Relapses in patients treated with fingolimod after previous exposure to natalizumab. Multiple Sclerosis (Houndmills, Basingstoke, England). 21: 786-90. PMID 25257618 DOI: 10.1177/1352458514549404  1
2015 Ebrahimi N, Herbstritt S, Gold R, Amezcua L, Koren G, Hellwig K. Pregnancy and fetal outcomes following natalizumab exposure in pregnancy. A prospective, controlled observational study. Multiple Sclerosis (Houndmills, Basingstoke, England). 21: 198-205. PMID 25159275 DOI: 10.1177/1352458514546790  1
2015 Thöne J, Kollar S, Nousome D, Ellrichmann G, Kleiter I, Gold R, Hellwig K. Serum anti-Müllerian hormone levels in reproductive-age women with relapsing-remitting multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). 21: 41-7. PMID 25145691 DOI: 10.1177/1352458514540843  1
2015 Gold R, Giovannoni G, Phillips JT, Fox RJ, Zhang A, Meltzer L, Kurukulasuriya NC. Efficacy and safety of delayed-release dimethyl fumarate in patients newly diagnosed with relapsing-remitting multiple sclerosis (RRMS). Multiple Sclerosis (Houndmills, Basingstoke, England). 21: 57-66. PMID 24990854 DOI: 10.1177/1352458514537013  1
2015 Vicente-Suarez I, Larange A, Reardon C, Matho M, Feau S, Chodaczek G, Park Y, Obata Y, Gold R, Wang-Zhu Y, Lena C, Zajonc DM, Schoenberger SP, Kronenberg M, Cheroutre H. Unique lamina propria stromal cells imprint the functional phenotype of mucosal dendritic cells. Mucosal Immunology. 8: 141-51. PMID 24938743 DOI: 10.1038/Mi.2014.51  1
2015 Kerasnoudis A, Pitarokoili K, Behrendt V, Gold R, Yoon MS. Correlation of nerve ultrasound, electrophysiological and clinical findings in chronic inflammatory demyelinating polyneuropathy. Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging. 25: 207-16. PMID 24593005 DOI: 10.1111/Jon.12079  1
2015 Martin DW, Lowery NE, Brand B, Gold R, Horlick G. Immunization information systems: a decade of progress in law and policy. Journal of Public Health Management and Practice : Jphmp. 21: 296-303. PMID 24402434 DOI: 10.1097/PHH.0000000000000040  1
2015 Kerasnoudis A, Pitarokoili K, Gold R, Yoon M. The Application of Clinical, Electrophysiological and Nerve Ultrasound Parameters in Distinguishing Acute-onset Chronic from Acute Inflammatory Demyelinating Polyneuropathy European Neurological Review. 10: 85. DOI: 10.17925/Enr.2015.10.01.85  1
2015 Kurre W, Berlis A, Diener HC, Fiehler J, Gold R, Groden C, Hamann GF, Röther J, Eckert B. IQWiG-Arbeitspapier GA15-02: Stents zur Behandlung intrakranieller Stenosen: VISSIT-Studie und Akutbehandlung in Deutschland Aktuelle Neurologie. 42: 441-444. DOI: 10.1055/S-0035-1552747  1
2015 Herbstritt S, Gold R, Hellwig K. Kinderwunsch und Multiple Sklerose Frauenheilkunde Up2date. 9: 133-151. DOI: 10.1055/S-0033-1358114  1
2015 Pitarokoili K, Schlamann M, Kerasnoudis A, Gold R, Yoon MS. Comparison of clinical, electrophysiological, sonographic and MRI features in CIDP Journal of the Neurological Sciences. DOI: 10.1016/j.jns.2015.07.030  1
2015 Yoon M-, Pitarokoili K, Gold R, Kerasnoudis A. P190. Nerve ultrasound and electrophysiology as monitoring methods of immune therapy in early onset chronic inflammatory demyelinating polyneuropathy Clinical Neurophysiology. 126. DOI: 10.1016/J.Clinph.2015.04.285  1
2015 Kerasnoudis A, Pitarokoili K, Woitalla D, Gold R, Yoon M-. P189. Sarcoid neuropathy: Correlation of nerve ultrasound, electrophysiological and clinical findings Clinical Neurophysiology. 126. DOI: 10.1016/J.Clinph.2015.04.284  1
2014 Chan A, Gold R. Anti-JC virus antibody testing for natalizumab-induced progressive multifocal leukoencephalopathy: Where are we and where should we go? Multiple Sclerosis (Houndmills, Basingstoke, England). 20: 771-2. PMID 27352428 DOI: 10.1177/1352458514532399  1
2014 Kappos L, Bar-Or A, Cree B, Fox R, Giovannoni G, Gold R, Vermersch P, Lam E, Pohlmann H, Wallström E. Siponimod (BAF312) for the treatment of secondary progressive multiple sclerosis: Design of the phase 3 EXPAND trial. Multiple Sclerosis and Related Disorders. 3: 752. PMID 25891589 DOI: 10.1016/j.msard.2014.09.185  1
2014 Phillips JT, Hutchinson M, Fox R, Gold R, Havrdova E. Managing flushing and gastrointestinal events associated with delayed-release dimethyl fumarate: Experiences of an international panel. Multiple Sclerosis and Related Disorders. 3: 513-9. PMID 25877064 DOI: 10.1016/J.Msard.2014.03.003  1
2014 Haghikia A, Faissner S, Pappas D, Pula B, Akkad DA, Arning L, Ruhrmann S, Duscha A, Gold R, Baranzini SE, Malhotra S, Montalban X, Comabella M, Chan A. Interferon-beta affects mitochondrial activity in CD4+ lymphocytes: Implications for mechanism of action in multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). PMID 25480861 DOI: 10.1177/1352458514561909  1
2014 Bunce AE, Gold R, Davis JV, McMullen CK, Jaworski V, Mercer M, Nelson C. Ethnographic process evaluation in primary care: explaining the complexity of implementation. Bmc Health Services Research. 14: 607. PMID 25475025 DOI: 10.1186/s12913-014-0607-0  1
2014 Kerasnoudis A, Woitalla D, Gold R, Pitarokoili K, Yoon MS. Sarcoid neuropathy: correlation of nerve ultrasound, electrophysiological and clinical findings. Journal of the Neurological Sciences. 347: 129-36. PMID 25439166 DOI: 10.1016/J.Jns.2014.09.033  1
2014 Angier H, Gregg J, Gold R, Crawford C, Davis M, DeVoe JE. Understanding how low-income families prioritize elements of health care access for their children via the optimal care model. Bmc Health Services Research. 14: 585. PMID 25406509 DOI: 10.1186/s12913-014-0585-2  1
2014 Lee DH, Heidecke H, Schröder A, Paul F, Wachter R, Hoffmann R, Ellrichmann G, Dragun D, Waschbisch A, Stegbauer J, Klotz P, Gold R, Dechend R, Müller DN, Saft C, et al. Increase of angiotensin II type 1 receptor auto-antibodies in Huntington's disease. Molecular Neurodegeneration. 9: 49. PMID 25398321 DOI: 10.1186/1750-1326-9-49  1
2014 DeVoe JE, Angier H, Burdick T, Gold R. Health information technology: an untapped resource to help keep patients insured. Annals of Family Medicine. 12: 568-72. PMID 25384821 DOI: 10.1370/afm.1721  1
2014 Heintzman J, Gold R, Krist A, Crosson J, Likumahuwa S, DeVoe JE. Practice-based research networks (PBRNs) are promising laboratories for conducting dissemination and implementation research. Journal of the American Board of Family Medicine : Jabfm. 27: 759-62. PMID 25381072 DOI: 10.3122/jabfm.2014.06.140092  1
2014 Hoepner R, Faissner S, Ellrichmann G, Schneider R, Gold R. Rituximab postprogressive multifocal leukoencephalopathy: a Feasible therapeutic option in selected cases. Therapeutic Advances in Neurological Disorders. 7: 289-91. PMID 25371711 DOI: 10.1177/1756285614556287  1
2014 Saft C, Siglienti I, Gold R, Schlamann M, Hindy NE, Sure U, Forsting M. High noon back pain- severe pseudoradicular pain as a lead symptom of superficial siderosis: a case report. Therapeutic Advances in Neurological Disorders. 7: 276-8. PMID 25371709 DOI: 10.1177/1756285614548189  1
2014 Elsey H, Bragg R, Elings M, Cade JE, Brennan C, Farragher T, Tubeuf S, Gold R, Shickle D, Wickramasekera N, Richardson Z, Murray J. Understanding the impacts of care farms on health and well-being of disadvantaged populations: a protocol of the Evaluating Community Orders (ECO) pilot study. Bmj Open. 4: e006536. PMID 25358678 DOI: 10.1136/Bmjopen-2014-006536  1
2014 Strassburger-Krogias K, Ellrichmann G, Krogias C, Altmeyer P, Chan A, Gold R. Fumarate treatment in progressive forms of multiple sclerosis: first results of a single-center observational study. Therapeutic Advances in Neurological Disorders. 7: 232-8. PMID 25342977 DOI: 10.1177/1756285614544466  1
2014 Faissner S, Hoepner R, Ellrichmann G, Trampe N, Lukas C, Gold R, Krogias C. Atypical occipital calcinosis in a Caucasian individual with probable diffuse neurofibrillary tangles with calcification. Journal of the American Geriatrics Society. 62: 2022-4. PMID 25333560 DOI: 10.1111/Jgs.13092  1
2014 Heintzman J, Gold R, Bailey SR, DeVoe JE. The Oregon experiment re-examined: the need to bolster primary care. Bmj (Clinical Research Ed.). 349: g5976. PMID 25331018 DOI: 10.1136/Bmj.G5976  1
2014 Kita M, Fox RJ, Gold R, Giovannoni G, Phillips JT, Sarda SP, Kong J, Viglietta V, Sheikh SI, Okwuokenye M, Kappos L. Effects of delayed-release dimethyl fumarate (DMF) on health-related quality of life in patients with relapsing-remitting multiple sclerosis: an integrated analysis of the phase 3 DEFINE and CONFIRM studies. Clinical Therapeutics. 36: 1958-71. PMID 25315404 DOI: 10.1016/J.Clinthera.2014.08.013  1
2014 Arnold DL, Gold R, Kappos L, Bar-Or A, Giovannoni G, Selmaj K, Yang M, Zhang R, Stephan M, Sheikh SI, Dawson KT. Magnetization transfer ratio in the delayed-release dimethyl fumarate DEFINE study. Journal of Neurology. 261: 2429-37. PMID 25270680 DOI: 10.1007/S00415-014-7504-7  1
2014 Curtis CR, Dorell C, Yankey D, Jeyarajah J, Chesson H, Saraiya M, Gold R, Dunne EF, Stokley S. National human papillomavirus vaccination coverage among adolescents aged 13-17 years-National Immunization Survey--teen, United States, 2011. Morbidity and Mortality Weekly Report. Surveillance Summaries (Washington, D.C. : 2002). 63: 61-70. PMID 25208260  1
2014 Puckett RT, Espinoza EM, Gold RE. Alate trap-based assessment of Formosan subterranean termite (Isoptera: Rhinotermitidae) dispersal flight phenology associated with an urbanized barrier island ecosystem. Environmental Entomology. 43: 868-76. PMID 25182611 DOI: 10.1603/EN13223  1
2014 Faissner S, Ambrosius B, Schanzmann K, Grewe B, Potthoff A, Münch J, Sure U, Gramberg T, Wittmann S, Brockmeyer N, Uberla K, Gold R, Grunwald T, Chan A. Cytoplasmic HIV-RNA in monocytes determines microglial activation and neuronal cell death in HIV-associated neurodegeneration. Experimental Neurology. 261: 685-97. PMID 25150097 DOI: 10.1016/J.Expneurol.2014.08.011  1
2014 Heintzman J, Marino M, Hoopes M, Bailey S, Gold R, Crawford C, Cowburn S, O'Malley J, Nelson C, DeVoe JE. Using electronic health record data to evaluate preventive service utilization among uninsured safety net patients. Preventive Medicine. 67: 306-10. PMID 25124279 DOI: 10.1016/J.Ypmed.2014.08.006  1
2014 Gold RM, Cohen ND, Lawhon SD. Amikacin resistance in Staphylococcus pseudintermedius isolated from dogs. Journal of Clinical Microbiology. 52: 3641-6. PMID 25078911 DOI: 10.1128/Jcm.01253-14  1
2014 Pitarokoili K, Ambrosius B, Schrewe L, Hayardeny L, Hayden M, Gold R. Laquinimod exerts strong clinical and immunomodulatory effects in Lewis rat experimental autoimmune neuritis. Journal of Neuroimmunology. 274: 38-45. PMID 25005118 DOI: 10.1016/J.Jneuroim.2014.06.012  1
2014 Arnold DL, Gold R, Kappos L, Bar-Or A, Giovannoni G, Selmaj K, Yang M, Zhang R, Stephan M, Sheikh SI, Dawson KT. Effects of delayed-release dimethyl fumarate on MRI measures in the Phase 3 DEFINE study. Journal of Neurology. 261: 1794-802. PMID 24989666 DOI: 10.1007/S00415-014-7412-X  1
2014 Sonfield A, Gold RB. Beyond consent to sterilization: facing up to the full range of barriers to post-abortion contraception. American Journal of Obstetrics and Gynecology. 211: 3-4. PMID 24972529 DOI: 10.1016/j.ajog.2014.05.021  1
2014 Angier H, Gold R, Gallia C, Casciato A, Tillotson CJ, Marino M, Mangione-Smith R, DeVoe JE. Variation in outcomes of quality measurement by data source. Pediatrics. 133: e1676-82. PMID 24864178 DOI: 10.1542/peds.2013-4277  1
2014 Kerasnoudis A, Pitarokoili K, Behrendt V, Gold R, Yoon MS. Multifocal motor neuropathy: correlation of nerve ultrasound, electrophysiological, and clinical findings. Journal of the Peripheral Nervous System : Jpns. 19: 165-74. PMID 24862982 DOI: 10.1111/Jns5.12067  1
2014 Hoepner R, Faissner S, Salmen A, Gold R, Chan A. Efficacy and side effects of natalizumab therapy in patients with multiple sclerosis. Journal of Central Nervous System Disease. 6: 41-9. PMID 24855407 DOI: 10.4137/JCNSD.S14049  1
2014 Manzel A, Domenig O, Ambrosius B, Kovacs A, Stegbauer J, Poglitsch M, Mueller DN, Gold R, Linker RA. Angiotensin IV is induced in experimental autoimmune encephalomyelitis but fails to influence the disease. Journal of Neuroimmune Pharmacology : the Official Journal of the Society On Neuroimmune Pharmacology. 9: 533-43. PMID 24854706 DOI: 10.1007/S11481-014-9548-Y  1
2014 Hoepner R, Havla J, Eienbröker C, Tackenberg B, Hellwig K, Meinl I, Hohlfeld R, Gold R, Kümpfel T, Kleiter I. Predictors for multiple sclerosis relapses after switching from natalizumab to fingolimod. Multiple Sclerosis (Houndmills, Basingstoke, England). 20: 1714-20. PMID 24842961 DOI: 10.1177/1352458514533398  1
2014 DeVoe JE, Gold R, Cottrell E, Bauer V, Brickman A, Puro J, Nelson C, Mayer KH, Sears A, Burdick T, Merrell J, Matthews P, Fields S. The ADVANCE network: accelerating data value across a national community health center network. Journal of the American Medical Informatics Association : Jamia. 21: 591-5. PMID 24821740 DOI: 10.1136/amiajnl-2014-002744  1
2014 Haghikia A, Langer-Gould A, Rellensmann G, Schneider H, Tenenbaum T, Elias-Hamp B, Menck S, Zimmermann J, Herbstritt S, Marziniak M, Kümpfel T, Meinl I, Plavina T, Gold R, Hellwig K. Natalizumab use during the third trimester of pregnancy. Jama Neurology. 71: 891-5. PMID 24821217 DOI: 10.1001/Jamaneurol.2014.209  1
2014 Faissner S, Grunwald C, Meves SH, Gold R, Krogias C. Teaching NeuroImages: sonographic "retrobulbar spot sign" in differentiating etiologies of sudden visual loss. Neurology. 82: e153-4. PMID 24778291 DOI: 10.1212/Wnl.0000000000000365  1
2014 Gold R, Fugger L. Multiple sclerosis: insights into pathophysiology and novel therapeutic avenues. Experimental Neurology. 262: 1. PMID 24751800 DOI: 10.1016/J.Expneurol.2014.04.012  1
2014 Reick C, Ellrichmann G, Thöne J, Scannevin RH, Saft C, Linker RA, Gold R. Neuroprotective dimethyl fumarate synergizes with immunomodulatory interferon beta to provide enhanced axon protection in autoimmune neuroinflammation. Experimental Neurology. 257: 50-6. PMID 24731948 DOI: 10.1016/J.Expneurol.2014.04.003  1
2014 Warnke C, von Geldern G, Markwerth P, Dehmel T, Hoepner R, Gold R, Pawlita M, Kümpfel T, Mäurer M, Stangel M, Wegner F, Hohlfeld R, Straeten V, Limmroth V, Weber T, et al. Cerebrospinal fluid JC virus antibody index for diagnosis of natalizumab-associated progressive multifocal leukoencephalopathy. Annals of Neurology. 76: 792-801. PMID 24729444 DOI: 10.1002/Ana.24153  1
2014 Hoepner R, Ahlbrecht J, Faissner S, Schneider R, Dahlhaus S, Adams O, Raab P, Lukas C, Chan A, Stangel M, Gold R. Clinical and paraclinical findings in natalizumab-associated infratentorial progressive multifocal leukoencephalopathy patients. Journal of Neurology, Neurosurgery, and Psychiatry. 85: 1177-8. PMID 24700881 DOI: 10.1136/Jnnp-2014-307582  1
2014 Fox RJ, Cree BA, De Sèze J, Gold R, Hartung HP, Jeffery D, Kappos L, Kaufman M, Montalbán X, Weinstock-Guttman B, Anderson B, Natarajan A, Ticho B, Duda P. MS disease activity in RESTORE: a randomized 24-week natalizumab treatment interruption study. Neurology. 82: 1491-8. PMID 24682966 DOI: 10.1212/Wnl.0000000000000355  1
2014 Haghikia A, Linker R, Gold R. [Fumaric acid as therapeutic agent for multiple sclerosis]. Der Nervenarzt. 85: 720-6. PMID 24668400 DOI: 10.1007/S00115-014-4005-Y  1
2014 Giovannoni G, Gold R, Selmaj K, Havrdova E, Montalban X, Radue EW, Stefoski D, McNeill M, Amaravadi L, Sweetser M, Elkins J, O'Neill G. Daclizumab high-yield process in relapsing-remitting multiple sclerosis (SELECTION): a multicentre, randomised, double-blind extension trial. The Lancet. Neurology. 13: 472-81. PMID 24656609 DOI: 10.1016/S1474-4422(14)70039-0  1
2014 Haghikia A, Gold R. Multiple sclerosis: TOWER confirms the efficacy of oral teriflunomide in MS. Nature Reviews. Neurology. 10: 183-4. PMID 24638132 DOI: 10.1038/Nrneurol.2014.42  1
2014 Rose-John S, Gold R. Devic disease: translational medicine at work. Neurology. 82: 1294-5. PMID 24634457 DOI: 10.1212/Wnl.0000000000000322  1
2014 Lühder F, Gold R. Trial and error in clinical studies: lessons from ATAMS. The Lancet. Neurology. 13: 340-1. PMID 24613348 DOI: 10.1016/S1474-4422(14)70050-X  1
2014 Gold R, Bailey SR, O?Malley JP, Hoopes MJ, Cowburn S, Marino M, Heintzman J, Nelson C, Fortmann SP, DeVoe JE. Estimating demand for care after a medicaid expansion: lessons from Oregon. The Journal of Ambulatory Care Management. 37: 282-92. PMID 24608921 DOI: 10.1097/Jac.0000000000000023  1
2014 Kerasnoudis A, Pitarokoili K, Behrendt V, Gold R, Yoon MS. Increased cerebrospinal fluid protein and motor conduction studies as prognostic markers of outcome and nerve ultrasound changes in Guillain-Barré syndrome. Journal of the Neurological Sciences. 340: 37-43. PMID 24607336 DOI: 10.1016/J.Jns.2014.02.019  1
2014 Tsivgoulis G, Sergentanis TN, Chan A, Voumvourakis K, Triantafyllou N, Psaltopoulou T, Gold R, Krogias C. Chronic cerebrospinal venous insufficiency and multiple sclerosis: a comprehensive meta-analysis of case-control studies. Therapeutic Advances in Neurological Disorders. 7: 114-36. PMID 24587827 DOI: 10.1177/1756285613499425  1
2014 May C, Nordhoff E, Casjens S, Turewicz M, Eisenacher M, Gold R, Brüning T, Pesch B, Stephan C, Woitalla D, Penke B, Janáky T, Virók D, Siklós L, Engelhardt JI, et al. Highly immunoreactive IgG antibodies directed against a set of twenty human proteins in the sera of patients with amyotrophic lateral sclerosis identified by protein array. Plos One. 9: e89596. PMID 24586901 DOI: 10.1371/Journal.Pone.0089596  1
2014 Heintzman J, Likumahuwa S, Nelson C, Eiff MP, Gold R, Carroll JE, Muench J, Hill C, Mital M, DeVoe JE. "Not a kidney or a lung:" research challenges in a network of safety net clinics. Family Medicine. 46: 105-11. PMID 24573517  1
2014 Salmen A, Gold R. Mode of action and clinical studies with fumarates in multiple sclerosis. Experimental Neurology. 262: 52-6. PMID 24568735 DOI: 10.1016/J.Expneurol.2014.02.015  1
2014 Matusch A, Saft C, Elmenhorst D, Kraus PH, Gold R, Hartung HP, Bauer A. Cross sectional PET study of cerebral adenosine A₁ receptors in premanifest and manifest Huntington's disease. European Journal of Nuclear Medicine and Molecular Imaging. 41: 1210-20. PMID 24566949 DOI: 10.1007/S00259-014-2724-8  1
2014 Michael YL, Nagel CL, Gold R, Hillier TA. Does change in the neighborhood environment prevent obesity in older women? Social Science & Medicine (1982). 102: 129-37. PMID 24565150 DOI: 10.1016/J.Socscimed.2013.11.047  1
2014 Angier H, Gold R, Crawford C, P O'Malley J, J Tillotson C, Marino M, DeVoe JE. Linkage methods for connecting children with parents in electronic health record and state public health insurance data. Maternal and Child Health Journal. 18: 2025-33. PMID 24562505 DOI: 10.1007/s10995-014-1453-8  1
2014 Heintzman J, Bailey SR, Hoopes MJ, Le T, Gold R, O'Malley JP, Cowburn S, Marino M, Krist A, DeVoe JE. Agreement of Medicaid claims and electronic health records for assessing preventive care quality among adults. Journal of the American Medical Informatics Association : Jamia. 21: 720-4. PMID 24508767 DOI: 10.1136/Amiajnl-2013-002333  1
2014 Godbeer SM, Gold RM, Lawhon SD. Prevalence of mupirocin resistance in Staphylococcus pseudintermedius. Journal of Clinical Microbiology. 52: 1250-2. PMID 24478408 DOI: 10.1128/Jcm.03618-13  1
2014 Naleway AL, Kurosky S, Henninger ML, Gold R, Nordin JD, Kharbanda EO, Irving S, Craig Cheetham T, Nakasato C, Glanz JM, Hambidge SJ, Davis RL, Klein NP, McCarthy NL, Weintraub E. Vaccinations given during pregnancy, 2002-2009: a descriptive study. American Journal of Preventive Medicine. 46: 150-7. PMID 24439348 DOI: 10.1016/J.Amepre.2013.10.010  1
2014 Hoepner R, Dahlhaus S, Kollar S, Zurawski B, Chan A, Kleiter I, Gold R, Hellwig K. Prophylactic antiepileptic treatment reduces seizure frequency in natalizumab-associated progressive multifocal leukoencephalopathy. Therapeutic Advances in Neurological Disorders. 7: 3-6. PMID 24409198 DOI: 10.1177/1756285613503515  1
2014 Bernhardt JM, Alber J, Gold RS. A social media primer for professionals: digital dos and don'ts. Health Promotion Practice. 15: 168-72. PMID 24396119 DOI: 10.1177/1524839913517235  1
2014 Gold RB, Hasstedt K, Frost JJ. Title X: a critical difference. Contraception. 89: 71-2. PMID 24378288 DOI: 10.1016/j.contraception.2013.12.005  1
2014 Chuang WY, Ströbel P, Bohlender-Willke AL, Rieckmann P, Nix W, Schalke B, Gold R, Opitz A, Klinker E, Inoue M, Müller-Hermelink HK, Saruhan-Direskeneli G, Bugert P, Willcox N, Marx A. Late-onset myasthenia gravis - CTLA4(low) genotype association and low-for-age thymic output of naïve T cells. Journal of Autoimmunity. 52: 122-9. PMID 24373506 DOI: 10.1016/J.Jaut.2013.12.006  1
2014 Salmen A, Gold R, Chan A. Management of disease-modifying treatments in neurological autoimmune diseases of the central nervous system. Clinical and Experimental Immunology. 176: 135-48. PMID 24358961 DOI: 10.1111/Cei.12258  1
2014 Brown MG, Gold RS. Cognitive responses to positively and negatively framed health messages: a thought-listing study. Psychology, Health & Medicine. 19: 724-9. PMID 24345327 DOI: 10.1080/13548506.2013.871305  1
2014 Gold R, Comi G, Palace J, Siever A, Gottschalk R, Bijarnia M, von Rosenstiel P, Tomic D, Kappos L. Assessment of cardiac safety during fingolimod treatment initiation in a real-world relapsing multiple sclerosis population: a phase 3b, open-label study. Journal of Neurology. 261: 267-76. PMID 24221641 DOI: 10.1007/S00415-013-7115-8  1
2014 Park GS, Wong WK, Khanna D, Gold RH, Paulus HE. Examining radiographic outcomes over time. Rheumatology International. 34: 271-9. PMID 24166210 DOI: 10.1007/s00296-013-2879-9  1
2014 Kappos L, Gold R, Arnold DL, Bar-Or A, Giovannoni G, Selmaj K, Sarda SP, Agarwal S, Zhang A, Sheikh SI, Seidman E, Dawson KT. Quality of life outcomes with BG-12 (dimethyl fumarate) in patients with relapsing-remitting multiple sclerosis: the DEFINE study. Multiple Sclerosis (Houndmills, Basingstoke, England). 20: 243-52. PMID 24150779 DOI: 10.1177/1352458513507817  1
2014 Kerasnoudis A, Pitarokoili K, Behrendt V, Gold R, Yoon MS. Nerve ultrasound score in distinguishing chronic from acute inflammatory demyelinating polyneuropathy. Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology. 125: 635-41. PMID 24070674 DOI: 10.1016/J.Clinph.2013.08.014  1
2014 Reiser M, Pittrow D, Stangel M, Gold R, Borte M, Fasshauer M, Kirch W, Huscher D, Baumann U, Hensel M. Management of secondary immunodeficiencies with immunoglobulins (IG) under clinical practice conditions. Journal of Clinical Oncology. 32. DOI: 10.1200/Jco.2014.32.15_Suppl.E17596  1
2014 Pitarokoili K, Kreuter A, Gold R, Kleiter I. Severe Raynaud’s phenomenon after treatment with interferon beta for multiple sclerosis Bmj. 349. DOI: 10.1136/Bmj.G6166  1
2014 Faissner S, Hoepner R, Gold R. Mikroglia im Kontext der Multiplen Sklerose Nervenheilkunde. 33: 805-810. DOI: 10.1055/S-0038-1627744  1
2014 Herbstritt S, Gold R, Hellwig K. Kinderwunsch und Multiple Sklerose Aktuelle Neurologie. 41: 476-490. DOI: 10.1055/S-0033-1337051  1
2014 Kerasnoudis A, Pitarokoili K, Behrendt V, Gold R, Yoon M-. P965: Correlation of nerve ultrasound, electrophysiological and clinical findings in chronic inflammatory demyelinating polyneuropathy Clinical Neurophysiology. 125. DOI: 10.1016/S1388-2457(14)50999-6  1
2014 Kerasnoudis A, Pitarokoili K, Behrendt V, Gold R, Yoon M-. YIA4: Bochum ultrasound score versus clinical and electrophysiologal parameters in distinguishing acute-onset chronic from acute inflammatory demyelinating polyneuropathy Clinical Neurophysiology. 125. DOI: 10.1016/S1388-2457(14)50100-9  1
2014 Schrewe L, Gold R, Chan A. Therapeutic implications of Apolipoprotein E genotype in autoimmune inflammatory diseases of the central nervous system Journal of Neuroimmunology. 275: 226. DOI: 10.1016/J.Jneuroim.2014.08.605  1
2014 Ellrichmann G, Reick C, Saft C, Thöne J, Hayardeny L, Gold R. Laquinimod treatment in a mouse model of Huntington's disease: A new neuroprotective therapy? Journal of Neuroimmunology. 275: 217-218. DOI: 10.1016/J.Jneuroim.2014.08.583  1
2014 Ellrichmann G, Straßburger-krogias K, Krogias C, Gold R. Fumarate treatment in patients with progressive forms of MS: First results of a single-center observational study Journal of Neuroimmunology. 275: 217. DOI: 10.1016/J.Jneuroim.2014.08.582  1
2014 Lühder F, Linker R, Lee D, Reichardt H, Bommhardt U, Gold R, Flügel A. Critical role of thymocyte-derived brain-derived neurotrophic factor in T cell maturation Journal of Neuroimmunology. 275: 202-203. DOI: 10.1016/J.Jneuroim.2014.08.544  1
2014 Stahlke S, Metzdorf J, Pedreitturia X, Leeuwen SV, Faissner A, Gold R, Kleiter I. Effects of interferon-beta on neural stem cells and in a mouse model of multiple sclerosis Journal of Neuroimmunology. 275: 193-194. DOI: 10.1016/J.Jneuroim.2014.08.521  1
2014 Böhme A, Schrewe L, Gold R, Chan A. Sex dependent influences of apolipoprotein E on the expression ATP-binding cassette transporters during experimental autoimmune encephalomyelitis Journal of Neuroimmunology. 275: 138. DOI: 10.1016/J.Jneuroim.2014.08.370  1
2014 Reick C, Ellrichmann G, Saft C, Linker R, Gold R. Efficacy and mechanisms of a combination therapy with dimethyl fumarate and Copolymer-1 in autoimmunity of the Central Nervous System Journal of Neuroimmunology. 275: 121. DOI: 10.1016/J.Jneuroim.2014.08.323  1
2014 Berg J, Bytko X, Waldhoff C, Gold R, Haghikia A. Effect of MS-related miRNA on astrocytic proliferation Journal of Neuroimmunology. 275: 111. DOI: 10.1016/J.Jneuroim.2014.08.298  1
2014 Haupeltshofer S, Wolf A, Pedreitturia X, Gold R, Kleiter I. T cell Smad7 modulates the gut immune response during spontaneous opticospinal encephalomyelitis Journal of Neuroimmunology. 275: 61-62. DOI: 10.1016/J.Jneuroim.2014.08.162  1
2014 Duscha A, Berg J, Thöne J, Demir S, Gold R, Haghikia A. Beneficial effects of short chain fatty acids on the course of experimental autoimmune encephalomyelitis Journal of Neuroimmunology. 275: 59. DOI: 10.1016/J.Jneuroim.2014.08.154  1
2013 Gold RS. Perceived likelihood of experiencing a desirable versus undesirable outcome. Psychological Reports. 113: 525-7. PMID 24597445 DOI: 10.2466/04.07.PR0.113x18z5  1
2013 Gold R, Oreja-Guevara C. Advances in the management of multiple sclerosis spasticity: multiple sclerosis spasticity guidelines. Expert Review of Neurotherapeutics. 13: 55-9. PMID 24289845 DOI: 10.1586/14737175.2013.865880  0.01
2013 Gold R. Multiple sclerosis spasticity management--key publications. Expert Review of Neurotherapeutics. 13: 47-8. PMID 24289843 DOI: 10.1586/14737175.2013.865875  0.01
2013 Gold R. Multiple sclerosis spasticity epidemiology--key publications. Expert Review of Neurotherapeutics. 13: 45-6. PMID 24289842 DOI: 10.1586/14737175.2013.865874  0.01
2013 Gold R. New insights into multiple sclerosis and advances in multiple sclerosis spasticity management. Expert Review of Neurotherapeutics. 13: 1-2. PMID 24289835 DOI: 10.1586/14737175.2013.865865  0.01
2013 Ahrens M, Turewicz M, Casjens S, May C, Pesch B, Stephan C, Woitalla D, Gold R, Brüning T, Meyer HE, Rahnenführer J, Eisenacher M. Detection of patient subgroups with differential expression in omics data: a comprehensive comparison of univariate measures. Plos One. 8: e79380. PMID 24278130 DOI: 10.1371/Journal.Pone.0079380  1
2013 Hatch B, Angier H, Marino M, Heintzman J, Nelson C, Gold R, Vakarcs T, Devoe J. Using electronic health records to conduct children's health insurance surveillance. Pediatrics. 132: e1584-91. PMID 24249814 DOI: 10.1542/peds.2013-1470  1
2013 Gold R. [Immunomodulation with oral dosage forms and their mechanisms of action]. Drug Research. 63: S9. PMID 24242042 DOI: 10.1055/s-0033-1346709  0.01
2013 Thöne J, Gold R. Review of laquinimod and its therapeutic potential in multiple sclerosis. Expert Opinion On Pharmacotherapy. 14: 2545-52. PMID 24215556 DOI: 10.1517/14656566.2013.848855  1
2013 Bailey SR, O'Malley JP, Gold R, Heintzman J, Likumahuwa S, DeVoe JE. Diabetes care quality is highly correlated with patient panel characteristics. Journal of the American Board of Family Medicine : Jabfm. 26: 669-79. PMID 24204063 DOI: 10.3122/Jabfm.2013.06.130018  1
2013 Zipp F, Gold R, Wiendl H. Identification of inflammatory neuronal injury and prevention of neuronal damage in multiple sclerosis: hope for novel therapies? Jama Neurology. 70: 1569-74. PMID 24145957 DOI: 10.1001/Jamaneurol.2013.4391  1
2013 Schmidt MA, Gold R, Kurosky SK, Daley MF, Irving SA, Gee J, Naleway AL. Uptake, coverage, and completion of quadrivalent human papillomavirus vaccine in the vaccine safety Datalink, July 2006-June 2011. The Journal of Adolescent Health : Official Publication of the Society For Adolescent Medicine. 53: 637-41. PMID 24138765 DOI: 10.1016/j.jadohealth.2013.08.002  1
2013 Prochnow N, Gold R, Haghikia A. An electrophysiologic approach to quantify impaired synaptic transmission and plasticity in experimental autoimmune encephalomyelitis. Journal of Neuroimmunology. 264: 48-53. PMID 24090654 DOI: 10.1016/J.Jneuroim.2013.09.012  1
2013 Linker RA, Gold R. Dimethyl fumarate for treatment of multiple sclerosis: mechanism of action, effectiveness, and side effects. Current Neurology and Neuroscience Reports. 13: 394. PMID 24061646 DOI: 10.1007/S11910-013-0394-8  1
2013 Kerasnoudis A, Pitarokoili K, Behrendt V, Gold R, Yoon MS. Correlation of nerve ultrasound, electrophysiological, and clinical findings in post Guillain-Barré syndrome. Journal of the Peripheral Nervous System : Jpns. 18: 232-40. PMID 24028191 DOI: 10.1111/Jns5.12037  1
2013 Gold RM, Lawhon SD. Incidence of inducible clindamycin resistance in Staphylococcus pseudintermedius from dogs. Journal of Clinical Microbiology. 51: 4196-9. PMID 24025915 DOI: 10.1128/Jcm.02251-13  1
2013 Kerasnoudis A, Décard BF, Gold R. Clinical reasoning: a 48-year-old woman with progressive spastic-ataxic gait. Neurology. 81: e75-80. PMID 24019389 DOI: 10.1212/Wnl.0B013E3182A43Ad9  1
2013 Haghikia A, Gold R. [Multiple sclerosis: oral drugs]. Mmw Fortschritte Der Medizin. 155: 54-6. PMID 24006598 DOI: 10.1007/S15006-013-2042-2  1
2013 Gold RM, Patterson AP, Lawhon SD. Understanding methicillin resistance in staphylococci isolated from dogs with pyoderma. Journal of the American Veterinary Medical Association. 243: 817-24. PMID 24004228 DOI: 10.2460/Javma.243.6.817  1
2013 Havrdova E, Hutchinson M, Kurukulasuriya NC, Raghupathi K, Sweetser MT, Dawson KT, Gold R. Oral BG-12 (dimethyl fumarate) for relapsing-remitting multiple sclerosis: a review of DEFINE and CONFIRM. Evaluation of: Gold R, Kappos L, Arnold D, et al. Placebo-controlled phase 3 study of oral BG-12 for relapsing multiple sclerosis. N Engl J Med 2012;367:1098-107; and Fox RJ, Miller DH, Phillips JT, et al. Placebo-controlled phase 3 study of oral BG-12 or glatiramer in multiple sclerosis. N Engl J Med 2012;367:1087-97. Expert Opinion On Pharmacotherapy. 14: 2145-56. PMID 23971970 DOI: 10.1517/14656566.2013.826190  1
2013 Lee DH, Stangel M, Gold R, Linker RA. The fumaric acid ester BG-12: a new option in MS therapy. Expert Review of Neurotherapeutics. 13: 951-8. PMID 23944289 DOI: 10.1586/14737175.2013.814958  1
2013 Mavrogiorgou P, Nalato F, Meves S, Luksnat S, Norra C, Gold R, Juckel G, Krogias C. Transcranial sonography in obsessive-compulsive disorder. Journal of Psychiatric Research. 47: 1642-8. PMID 23932243 DOI: 10.1016/J.Jpsychires.2013.07.020  1
2013 Schwab N, Schneider-Hohendorf T, Posevitz V, Breuer J, Göbel K, Windhagen S, Brochet B, Vermersch P, Lebrun-Frenay C, Posevitz-Fejfár A, Capra R, Imberti L, Straeten V, Haas J, Wildemann B, ... ... Gold R, et al. L-selectin is a possible biomarker for individual PML risk in natalizumab-treated MS patients. Neurology. 81: 865-71. PMID 23925765 DOI: 10.1212/Wnl.0B013E3182A351Fb  1
2013 Brück W, Gold R, Lund BT, Oreja-Guevara C, Prat A, Spencer CM, Steinman L, Tintoré M, Vollmer TL, Weber MS, Weiner LP, Ziemssen T, Zamvil SS. Therapeutic decisions in multiple sclerosis: moving beyond efficacy. Jama Neurology. 70: 1315-24. PMID 23921521 DOI: 10.1001/Jamaneurol.2013.3510  1
2013 Puckett RT, Calixto AA, Reed JJ, McDonald DL, Drees BB, Gold RE. Effectiveness comparison of multiple sticky-trap configurations for sampling Pseudacteon spp. phorid flies (Diptera: Phoridae). Environmental Entomology. 42: 763-9. PMID 23905740 DOI: 10.1603/EN13150  1
2013 Bellenberg B, Busch M, Trampe N, Gold R, Chan A, Lukas C. 1H-magnetic resonance spectroscopy in diffuse and focal cervical cord lesions in multiple sclerosis. European Radiology. 23: 3379-92. PMID 23884299 DOI: 10.1007/S00330-013-2942-7  1
2013 Harbo HF, Gold R, Tintoré M. Sex and gender issues in multiple sclerosis. Therapeutic Advances in Neurological Disorders. 6: 237-48. PMID 23858327 DOI: 10.1177/1756285613488434  0.01
2013 Bar-Or A, Gold R, Kappos L, Arnold DL, Giovannoni G, Selmaj K, O'Gorman J, Stephan M, Dawson KT. Clinical efficacy of BG-12 (dimethyl fumarate) in patients with relapsing-remitting multiple sclerosis: subgroup analyses of the DEFINE study. Journal of Neurology. 260: 2297-305. PMID 23797999 DOI: 10.1007/s00415-013-6954-7  1
2013 Krogias C, Hoepner R, Müller A, Schneider-Gold C, Schröder A, Gold R. Successful treatment of anti-Caspr2 syndrome by interleukin 6 receptor blockade through tocilizumab. Jama Neurology. 70: 1056-9. PMID 23778873 DOI: 10.1001/Jamaneurol.2013.143  1
2013 Krogias C, Fischer G, Meves SH, Gold R, Juckel G, Norra C. Brainstem raphe alterations depicted by transcranial sonography do not result in serotonergic functional impairment. Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging. 23: 477-83. PMID 23751197 DOI: 10.1111/Jon.12038  1
2013 Younis RH, Gold R, Reich RF. Clinical pathologic conference case 3: Painful, mobile mandibular molar. Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology. 115: e40-4. PMID 23738344  0.01
2013 Angier H, Wiggins N, Gregg J, Gold R, DeVoe J. Increasing the relevance of research to underserved communities: lessons learned from a retreat to engage community health workers with researchers. Journal of Health Care For the Poor and Underserved. 24: 840-9. PMID 23728049 DOI: 10.1353/hpu.2013.0086  1
2013 Stroet A, Linker RA, Gold R. Advancing therapeutic options in multiple sclerosis with neuroprotective properties. Journal of Neural Transmission (Vienna, Austria : 1996). 120: S49-53. PMID 23720188 DOI: 10.1007/S00702-013-1037-6  1
2013 Kwon HT, Ma GX, Gold RS, Atkinson NL, Wang MQ. Primary care physicians' cancer screening recommendation practices and perceptions of cancer risk of Asian Americans. Asian Pacific Journal of Cancer Prevention : Apjcp. 14: 1999-2004. PMID 23679307 DOI: 10.7314/Apjcp.2013.14.3.1999  1
2013 Devoe JE, Gold R. Community of solution for the U.S. health care system: lessons from the U.S. educational system. Journal of the American Board of Family Medicine : Jabfm. 26: 323-6. PMID 23657701 DOI: 10.3122/jabfm.2013.03.120308  1
2013 Naleway AL, Gold R, Kurosky S, Riedlinger K, Henninger ML, Nordin JD, Kharbanda EO, Irving S, Cheetham TC, McCarthy NL. Identifying pregnancy episodes, outcomes, and mother-infant pairs in the Vaccine Safety Datalink. Vaccine. 31: 2898-903. PMID 23639917 DOI: 10.1016/j.vaccine.2013.03.069  1
2013 Turewicz M, May C, Ahrens M, Woitalla D, Gold R, Casjens S, Pesch B, Brüning T, Meyer HE, Nordhoff E, Böckmann M, Stephan C, Eisenacher M. Improving the default data analysis workflow for large autoimmune biomarker discovery studies with ProtoArrays. Proteomics. 13: 2083-7. PMID 23616427 DOI: 10.1002/Pmic.201200518  1
2013 Dahlhaus S, Hoepner R, Chan A, Kleiter I, Adams O, Lukas C, Hellwig K, Gold R. Disease course and outcome of 15 monocentrically treated natalizumab-associated progressive multifocal leukoencephalopathy patients. Journal of Neurology, Neurosurgery, and Psychiatry. 84: 1068-74. PMID 23606731 DOI: 10.1136/Jnnp-2013-304897  1
2013 Parida L, Fernandez-Pineda I, Uffman J, Davidoff AM, Gold R, Rao BN. Thoracoscopic resection of computed tomography-localized lung nodules in children. Journal of Pediatric Surgery. 48: 750-6. PMID 23583129 DOI: 10.1016/j.jpedsurg.2012.09.051  1
2013 Kerasnoudis A, Pitarokoili K, Behrendt V, Gold R, Yoon MS. Cross sectional area reference values for sonography of peripheral nerves and brachial plexus. Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology. 124: 1881-8. PMID 23583024 DOI: 10.1016/J.Clinph.2013.03.007  1
2013 Haghikia A, Hohlfeld R, Gold R, Fugger L. Therapies for multiple sclerosis: translational achievements and outstanding needs. Trends in Molecular Medicine. 19: 309-19. PMID 23582699 DOI: 10.1016/J.Molmed.2013.03.004  1
2013 Gold R, Giovannoni G, Selmaj K, Havrdova E, Montalban X, Radue EW, Stefoski D, Robinson R, Riester K, Rana J, Elkins J, O'Neill G. Daclizumab high-yield process in relapsing-remitting multiple sclerosis (SELECT): a randomised, double-blind, placebo-controlled trial. Lancet (London, England). 381: 2167-75. PMID 23562009 DOI: 10.1016/S0140-6736(12)62190-4  1
2013 Michael YL, Gold R, Perrin N, Hillier TA. Built environment and change in body mass index in older women. Health & Place. 22: 7-10. PMID 23531924 DOI: 10.1016/J.Healthplace.2013.02.001  1
2013 Greenberg BM, Balcer L, Calabresi PA, Cree B, Cross A, Frohman T, Gold R, Havrdova E, Hemmer B, Kieseier BC, Lisak R, Miller A, Racke MK, Steinman L, Stuve O, et al. Interferon beta use and disability prevention in relapsing-remitting multiple sclerosis. Jama Neurology. 70: 248-51. PMID 23530268 DOI: 10.1001/Jamaneurol.2013.1017  1
2013 Rosso AL, Eaton CB, Wallace R, Gold R, Stefanick ML, Ockene JK, Curb JD, Michael YL. Geriatric syndromes and incident disability in older women: results from the women's health initiative observational study. Journal of the American Geriatrics Society. 61: 371-9. PMID 23452034 DOI: 10.1111/Jgs.12147  1
2013 Sisul DM, Liss MA, Palazzi KL, Briles K, Mehrazin R, Gold RE, Masterson JH, Mirheydar HS, Jabaji R, Stroup SP, L'Esperance JO, Wake RW, Rivera-Sanfeliz G, Derweesh IH. RENAL nephrometry score is associated with complications after renal cryoablation: a multicenter analysis. Urology. 81: 775-80. PMID 23434099 DOI: 10.1016/j.urology.2012.11.037  1
2013 Stüwe SH, Goetze O, Lukas C, Klotz P, Hoffmann R, Banasch M, Orth M, Schmidt WE, Gold R, Saft C. Hepatic mitochondrial dysfunction in manifest and premanifest Huntington disease. Neurology. 80: 743-6. PMID 23390182 DOI: 10.1212/Wnl.0B013E318282514E  1
2013 Puckett RT, McDonald DL, Gold RE. Comparison of multiple steam treatment durations for control of bed bugs (Cimex lectularius L.). Pest Management Science. 69: 1061-5. PMID 23371878 DOI: 10.1002/ps.3467  1
2013 Ayzenberg I, Kleiter I, Schröder A, Hellwig K, Chan A, Yamamura T, Gold R. Interleukin 6 receptor blockade in patients with neuromyelitis optica nonresponsive to anti-CD20 therapy. Jama Neurology. 70: 394-7. PMID 23358868 DOI: 10.1001/Jamaneurol.2013.1246  1
2013 Gold RS. The days are long and the years are short: a year in the shoes of a SOPHE president. Health Education & Behavior : the Official Publication of the Society For Public Health Education. 40: 640-5. PMID 23345338 DOI: 10.1177/1090198112473113  1
2013 Kerasnoudis A, Meves SH, Gold R, Krogias C. Correlation between frequency of microembolic signals and efficacy of antiplatelet therapy in symptomatic carotid disease. Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging. 23: 484-8. PMID 23317001 DOI: 10.1111/J.1552-6569.2012.00770.X  1
2013 Gold R, Naleway A, Riedlinger K. Factors predicting completion of the human papillomavirus vaccine series. The Journal of Adolescent Health : Official Publication of the Society For Adolescent Medicine. 52: 427-32. PMID 23298984 DOI: 10.1016/j.jadohealth.2012.09.009  1
2013 Lühder F, Gold R, Flügel A, Linker RA. Brain-derived neurotrophic factor in neuroimmunology: lessons learned from multiple sclerosis patients and experimental autoimmune encephalomyelitis models. Archivum Immunologiae Et Therapiae Experimentalis. 61: 95-105. PMID 23283517 DOI: 10.1007/S00005-012-0211-0  1
2013 Pitarokoili K, Dahlhaus S, Hellwig K, Boehm S, Neubauer H, Gold R, Krogias C. Ventricular tachycardia during basilar-type migraine attack. Therapeutic Advances in Neurological Disorders. 6: 35-40. PMID 23277791 DOI: 10.1177/1756285612463625  1
Show low-probability matches.